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Abstract
Exposure to chemical carcinogens is believed to be an important etiological
factor in human cancer. Carcinogen-DNA adducts are considered to represent the
initiating events leading to cancer. This dissertation was undertaken to determine the
DNA adduct formation by cyclopenta[cd]pyrene (CPP), a ubiquitous environmental
carcinogen, in vitro and in mice.
Calf thymus DNA was reacted in vitro with CPP 3,4-epoxide (CPPE) or
with its metabolites, 3,4-dihydroCPP-3,4-diol (CPP-3,4-diol) and 4-hydroxy-3,4-
dihydroCPP (4-OH-DCPP), activated with sulfotransferase. The results demonstrated
that the two major CPPE-derived adducts were formed by guanine, while minor
adducts were formed by adenine and cytosine. Specifically, the major dG adduct
formed in DNA was identified as cis-3-(deoxyguanosin-N2-yl)-4-hydroxy-3,4-
dihydroCPP (3-dG-4-OH-DCPP) and the minor dG adduct seems likely to be its
trans isomer. Adenosine adducts were presumably formed by aralkylation of the N6
position since they co-chromatographed with regio-specifically synthesized
standards. Sulfotransferase activation of trans-CPP-3,4-diol yielded two adducts that
were identical to the products resulting from the reaction of CPPE with DNA, while
cis-CPP-3,4-diol gave very low covalent binding. Adducts formed by
sulfotransferase activation of 4-OH-DCPP were identical to the diastereomeric
products generated from the reaction of synthetic 4-NaO3 S-O-DCPP with dG. These
results indicate that guanine is predominantly the site of CPP adduct formation in
DNA, regardless of the identity of the reactive metabolite, and that the 4-hydroxy-3-
dG adducts can arise by reaction of DNA with either CPPE or sulfotransferase-
activated trans-CPP-3,4-diol.
In CPP-treated CD-1 mice, four and six peaks were detected in the DNA
digests of liver and lung samples, respectively, by HPLC. Cryogenic fluorescence
spectroscopic analysis indicated that all peaks were derived from CPPE. These
peaks were also identified by their chromatographic similarity to synthetic CPP
metabolites and adduct standards formed in vitro. The results suggest that adducts
detected in liver DNA digests are trans-3-dG-4-OH-DCPP, two diastereomers of cis-
3-dG-4-OH-DCPP, and trans-3-deoxyadenosinyl-4-hydroxy-3,4-dihydroCPP (3-dA-
4-OH-DCPP). Adducts detected in lung samples are probably trans-3-dG-4-OH-
DCPP, two diastereomers of cis-3-dG-4-OH-DCPP, cis-CPP-3,4-diol, cis-3-dA-4-
OH-DCPP, and 4-OH-DCPP. The detection of CPP-3,4-diol and 4-OH-DCPP
suggests that the formation of unstable adducts by CPP. Furthermore, both CPPE
and sulfotransferase-activated trans-CPP-3,4-diol could be the major ultimate
carcinogenic metabolites of CPP, while sulfotransferase-activated 4-OH-DCPP could
be a minor one.
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1. Introduction
Exposure to chemical carcinogens is believed to be an important etiological
factor in human cancer. Carcinogen-DNA adducts are considered to represent the
initiating events leading to mutations and malignant transformation, which ultimately
lead to cancer. The determination of DNA adduct formation and levels in vivo,
therefore, can reveal both the DNA damage and exposure to the carcinogens. In
addition, addressing the DNA adduct formation of the major metabolic products of
a carcinogen in vitro can provide information about the roles that these metabolites
may play in the formation of DNA adducts in vivo.
Cyclopenta[cd]pyrene (CPP, Figure 2.1) is a widespread environmental
pollutant produced by incomplete combustion. It is found in, for example, carbon
black (Wallcave et al., 1975), cigarette smoke (Snook et al., 1977), automobile
exhaust (Stenberg et al., 1983), and rural and urban air particulate (Grimmer et al.,
1980; Nielsen, 1983) and generally co-occurs with benzo[a]pyrene (BaP). CPP may
be as much as 10- to 20 fold more abundant than BaP (Grimmer et al., 1977;
Grimmer, 1979; Skopek et al., 1979). It shows high mutagenicity upon bioactivation
in both bacterial and mammalian cells (Wood et al., 1980; Raveh et al., 1982;
Eisenstadt and Gold, 1978; Cavalieri et al., 1981b). In addition, CPP is a strong
inducer of adenocarcinoma in newborn mice (Busby et al., 1988), adenomas in
weanling A/J mice (Nesnow et al., 1994), and is carcinogenic in mouse skin
bioassays (Wood et al., 1980; Raveh et al., 1982). CPP was more potent than BaP
in at least three studies including its mutagenicity in bacteria, induction of malignant
tumors, and tumorigenicity of A/J mouse lung (Eisenstadt and Gold, 1978; Busby
et al., 1988; Nesnow et al., 1994).
CPP is one of a series of cyclopenta-fused polycyclic aromatic hydrocarbon
(PAH), which, if lacking a bay region, may be metabolically activated by
epoxidation of the fixed double bond in the 5-membered ring. The resulting 3,4-
epoxide of CPP is often considered to be the ultimate carcinogen, though evidence
for diol epoxides as reactive electrophiles has also been presented (Sahali et al.,
1992; Kwon et al., 1992). The principal adducts formed by CPP 3,4-epoxide (CPPE)
with DNA, both in vivo and in vitro, have been characterized as products of
reaction with guanine (Nesnow et al., 1994; Beach et al., 1993; Beach and Gupta,
1994). While the structures of the guanine adducts have not yet been elucidated,
they are commonly thought to be the 4-hydroxy-3-(N2-guanyl)dihydroCPP. The
first part of this dissertation describes detailed information regarding the regio- and
stereo-chemistry of guanine adduct formation by CPPE.
Two important metabolites of CPPE, 3,4-dihydroCPP-3,4-diol (CPP-3,4-diol)
and 4-hydroxy-3,4-dihydroCPP (4-OH-DCPP), have been shown to react with DNA
and to be mutagenic when activated by sulfotransferase. The first of these would be
expected to produce the same adduct as CPPE. 4-OH-DCPP would yield a unique
adduct but there is no certainty that it would be separated from dG-CPP under the
chromatographic conditions used to detect in vivo adducts (Nesnow et al., 1994;
Beach and Gupta, 1994). The second part of this dissertation characterizes the
binding of these two secondary metabolites with DNA and determines if bases other
than guanine are alkylated by CPPE.
In the third and final section, the identification of adducts formed in a mouse
model is reported along with the inference of adduct-forming metabolites of CPP.
To our knowledge this is the first report to investigate the formation of PAH-DNA
adducts in vivo by laser-induced fluorescence spectroscopy without adduct
hydrolysis.
2. Literature Survey
2.1 Polycyclic aromatic hydrocarbons
2.1.1. Source and composition
Polycyclic aromatic hydrocarbons (PAHs) contain two or more fused benzene
rings in angular, linear or cluster arrangements. They can be produced by
incomplete combustion or high temperature pyrolytic processes involving fossil fuels
(Badger, 1962), and by definition PAHs consist of only C and H. PAHs were one
of the first atmospheric contaminants to be identified as being carcinogenic. These
compounds are ubiquitous in the urban atmosphere. Therefore, they have undergone
considerable examination. Recently, attention has focused on the possible adverse
effects on human health of these chemical carcinogens in the atmospheric
environment (Baek et al., 1991).
Several environmental pathways including diet can contribute to human
exposure to PAHs (Basu and Saxena, 1978; Lijinsky and Ross, 1967; Baek et al.,
1991; Higginson and Muir, 1976). However, the occurrence of PAHs in ambient
air has caused the most concern due to the size of risk population and the
continuous exposure, especially in urban, suburban and industrial areas. The
concentration of PAHs in ambient air, PAH distribution between the gaseous and
particulate phases, and the size of the PAH particles are some factors that are
associated with the extent of human exposure to PAHs. In addition, the evaluation
of the physical and chemical characteristics of airborne PAHs as well as the
identification of the major emission sources of PAHs are two major parameters for
assessing the significance of PAHs in ambient air.
PAH emissions from human activities are the predominant source even
though some PAHs can arise from the natural combustion such as volcanic eruptions
and forest fires (Nikolaou et al., 1984). The sources of PAH can generally be
divided into mobile and stationary categories. Vehicular petrol and diesel engines
are the major contributors in the mobile category. Within the stationary category,
a wide variety of combustion processes, including residential heating, industrial
activities (e.g., aluminum production and coke manufacture), incineration and power
generation (Hangerbrauck et al., 1967; United States National Academy of Sciences,
1972), may all produce high atmospheric PAH concentrations in the vicinity of the
major emitters (Baek et al., 1991; United States National Academy of Sciences,
1983).
The composition of PAHs produced from different pyrolytic processes varies.
It depends upon the combustion conditions and the fuel type (Blumer, 1976;
Westerholm et al., 1988). For instance, high BaP concentrations seem to arise from
low temperature combustion (Freeman and Cattell, 1990). Other factors such as the
emission rate of the PAH source and the local climatic conditions can also make
certain contribution to the atmospheric PAHs (Harkov and Greenberg, 1985).
Nevertheless, it has been estimated that the stationary sources account for
approximately 90% of the total PAH emissions with the remainder produced by
mobile source. But in urban or suburban areas, where major stationary sources are
not present, mobile sources contribute the majority of PAHs (Back et al., 1991;
United States National Academy of Sciences, 1983).
BaP was the first identified carcinogenic PAH found in coal tar (Cook et al.,
1933). Because of its early identification, BaP has been investigated extensively
and used as a model compound for PAHs. However, it is only one of many
carcinogenic PAHs including benzo[a]anthracene, benzo[b]fluoranthene,
indeno[cd]pyrene, 7,12-dimethylbenzo[a]anthracene (DMBA), and
dibenzo[ae]pyrene. Therefore, using BaP as the sole or even a main indicator to
assess the impact of human exposure to PAH mixtures on health obviously raises
question. In soot extract, for example, CPP (Figure 2.1), fluoranthene (FA) and
perylene occur in greater amounts than BaP and account for the major mutagenicity
of the soot extract using a bacterial forward mutation assay (Kaden et al., 1979).
CPP and FA also exhibit potent biological effects and have been recognized as
potential health hazards, such as in human cell forward mutation assays (Skopek et
al., 1979). Identification of all the components of PAH mixtures is time-consuming.
Thus, it seems practical to select known index substances for the health effects
posed by PAHs. This approach should be valid if it is based on the
amount/concentration and genotoxicity of each PAH compound from different
sources.
CPP belongs to a unique class of cyclopenta-fused PAHs (CP-PAHs). It has
been identified, for instance, in coal-tar pitch (Wallcave, 1969), carbon black
(Wallcave et al., 1975), and cigarette smoke (Snook et al., 1977). The level of CPP
in gasoline auto exhaust condensates is 8 to 25 times higher than that of BaP (Tong
and Karasek, 1984; Grimmer et al., 1977; Grimmer, 1979). In a diesel engine
exhaust analysis, the amount of CPP has been shown to be equal to the sum of BaP,
benzo[e]pyrene and perylene (Schuetzle et al., 1981). In the mixture of kerosene
soot extract, CPP is also the major contributor of mutagenicity (Skopek et al., 1979).
Being more mutagenic and structurally intriguing, CPP, at concentrations equal to
or higher than that of BaP , may be a good indicator of health risk associated with
exposure to PAH mixtures.
2.1.2 Metabolism of cyclopenta[cd]pyrene
The ultimate carcinogenic form of CPP is not known since no DNA adduct
structures have yet been determined. Epoxidation of the 3,4 double bond which
forms the cyclopenta ring appears to be the major microsomal metabolic pathway
(Eisenstadt et al., 1981; Gold and Eisenstadt, 1980; Sahali et al., 1992; Kwon et al.,
1992). Therefore, it has been suggested that the 3,4-epoxide may be the ultimate
carcinogen derived from CPP. This hypothesis was also supported by the
preponderance of 3,4-dihydrodiol among the products of microsomal metabolism
(Eisenstadt et al., 1981; Gold and Eisenstadt, 1980; Sahali et al., 1992; Kwon et al.,
1992) and by perturbation molecular orbital (PMO) calculations (Fu et al., 1980).
The PMO approach to CPP has shown that the 3,4 double bond of the penta-
fused ring of CPP possesses the highest bond order and is thus the most olefinic
double bond. The olefinic characteristic of the highly localized double bond renders
the five-member ring of CPP very suspectable to epoxidation (Fu et al., 1980).
Also, the carbonium ion resulting from the ring opening of the penta ring epoxide
can be stabilized by the pyrene of CPP. Similarly, the carbonium ion derived from
CPP 3,4-epoxide (CPPE) also appears in the bay region of tetrahydrobenzo-ring
epoxies of PAHs (Figure 2.2) (Eisenstadt and Gold, 1978). The mutagenicity of
several oxygenated derivatives of CPP, however, casts some uncertainty on the role
of CPPE as a DNA-binding metabolite. For instance, cis-3,4-dihydroxy-3,4-
dihydroCPP (CPP-3,4-diol) is more mutagenic than 3-hydroxy-3,4-dihydroCPP. The
isomeric trans-3,4-diol and the related 4-hydroxy and 3 or 4-keto derivatives are
also potent mutagens using Salmonella typhimurium strain TM677 forward mutation
assay (Santella et al., 1985).
Incubation of CPP with rat liver microsomal system has been reported to
yield two major metabolites, the trans-3,4-dihydrodiol and the trans-9,10-
dihydrodiol (Gold and Eisenstadt, 1980). The formation of 3,4-dihydrodiol
suggested that 3,4-epoxide is transiently formed, and the formation of a 9,10-
dihydrodiol indicated that oxidation is not limited to the 3,4 double bond in CPP.
Since CPP is a mouse carcinogen, the metabolism of CPP by both mouse and
human live microsomes was determined (Sahali et al., 1992). This study identified
additional CPP metabolites from which the identities of genotoxic alkylating species
might be deduced. The major metabolite was still trans-3,4-diol as previously found
in rat liver microsomal incubation. In addition, cis-3,4-diol, 4-hydroxy-3,4-
dihydroCPP (4-OH-DCPP), and 4-oxo-3,4-dihydroCPP were observed. Two extra
pairs of metabolites were characterized as isomeric tetrahydrotetrols and
dihydrotriols. The trans-3,4-dihydrodiol functionality was found in the
dihydrotriols. Further investigation also showed that either 3,4- or 9,10-trans-
dihydrodiol could serve as the precursor of the tetrahydrotetrols. The updated
metabolic pathway of CPP, summarized from this study, is shown in Figure 2.3.
Oxidation of CPP by mouse and human microsomes and selected cytochrome
P450 enzymes has been investigated recently and a basis for interspecies comparison
was established (Kwon et al., 1992). All the CPP metabolites identified from the
mouse liver microsomal incubations were also observed in human samples.
However, three human microsomal samples produced different amounts of these
metabolites. The microsomes derived from genetically engineered cells containing
specific cytochrome P450 isozyme cDNAs were employed to examine the variation
among human samples. These studies suggested the possibility of the 3,4-
dihydrodiol 9,10-epoxide and the 9,10-dihydrodiol 3,4-epoxide of CPP.
2.1.3 Biological effects of CPP
The biological effects of CPP have not to date been studied extensively
especially when compared to BaP. Studies show that biological activity of a
number of PAHs results from metabolism to bay region diol-epoxides, which are
capable of forming covalent adducts at nucleophilic sites within DNA. CPP has
evoked considerable interest because it has a wide environmental distribution and
it lacks a bay region.
Cyclopenta-fused PAH (CP-PAH) is a unique class of PAHs that is abundant
in the effluent from a number of different combustion systems and is also present
in airborne particulate matter (Gold, 1975; Yergey et al., 1982; Prado et al., 1981;
Nesnow et al., 1981; Cavalieri et al., 1981b; Nesnow et al., 1984). Many CP-PAHs
have been revealed to be mutagenic and animal carcinogenic and thus potentially
pose a significant health threat to humans (Gold, 1975; Nesnow et al., 1981;
Nesnow et al., 1984). CPP, one of several C18H 10 CP-PAH products from different
combustors and pyrolyzers operated over a wide range of conditions, was found to
be the most important bacterial mutagen emitted from a jet-stirred/plug-flow reactor
(Prado et al., 1981). Recently, three of the other C18 H10 CP-PAHs including
cylcopent[hi]acephenanthrylene (CPAP), cyclopent[hi]aceanthrylene (CPAA) and
benzo[ghi]fluoranthene (BF) were also identified. These four C18H10 isomers,
together with BaP, were tested in bacterial and human cell mutagenicity assays. In
a forward mutation assay using Salmonella typhimurium, CPP, BF and CPAA were
roughly twice as mutagenic as BaP, whereas CPAP was only slightly active. In a
human cell mutagenicity assay using MCL-3 cells, a derivative of AHH-1 TK + -
cells containing high P450 1A1 activity, CPP and CPAA were strongly mutagenic
but less active than BaP, while CPAP and BF were inactive at the dose levels tested
(Lafleur et al., 1993).
The 3,4-epoxide of CPP has been synthesized and shown to be a powerful
direct-acting mutagen to Salmonella typhimurium (Cavalieri et al., 1981b; Gold et
al., 1979). It was also suspected as the ultimate mutagenic metabolite of the parent
molecule as mentioned before. Again, the confirmation of the 3,4-epoxide as a
primary metabolite and ultimate mutagen was mainly based on the identification of
trans-3,4-diol as a major metabolic product from various enzymatic incubations
(Eisenstadt et al., 1981; Gold and Eisenstadt, 1980; Sahali et al., 1992; Kwon et al.,
1992).
3,4-Dihydrocyclopenta[cd]pyrene (DHCPP), the 3,4-dehydrogenated
derivative of CPP, is a constituent of coal tar pitch and also widely distributed in
the environment (Wallcave et al., 1975; Wallcave, 1969). In an earlier study, it was
examined for its carcinogenicity, mutagenicity and DNA binding compared with
CPP and its derivatives (Cavalieri et al., 1981b). In a bacterial mutation assay,
DHCPP was several times less mutagenic than CPP. Nonetheless, DHCPP exhibited
greater mutagenic activity than pyrene, indicating that the five-member ring
contributes to the activity of DHCPP. The oxygenated derivatives of DHCPP at the
3 and 4 positions, including 3- and 4- ketone and hydroxy CPP, showed the same
relatively low mutagenicity as DHCPP. The cis-3,4-diol was approximately as
mutagenic as CPP and BaP. In contrast, trans-3,4,-diol was the least mutagenic
compound in these CPP and its derivatives. Since its level of tumor-initiating
activity is similar to that of benzo[a]anthracene, CPP was considered to be a weak
tumor initiator in mouse skin (Wood et al., 1980). DHCPP was inactive in both
initiation-promotion and repeated application tumorigenicity experiments on mouse
skin. Although less active than BaP, CPP was moderately potent as a complete
carcinogen in mouse skin (Cavalieri et al., 1981; Cavalieri et al., 1983).
Interestingly, most of the CPP-induced neoplasms were malignant (Busby et al.,
1988) and some metastasized to lung and lymph nodes (Cavalieri et al., 1983). The
tumorigenic inactivity of DHCPP suggests that the carcinogenic effect of CPP may
be due to formation of the predicted ultimate derivative CPPE. The involvement
of epoxidation of 3,4 double bond on CPP is also strengthened by the high binding
of CPP to mouse skin nucleic acids in vivo, whereas binding of DHCPP was
insignificant (Cavalieri et al., 1981b).
Other biological effects of CPP include its mutagenicity to V79 cells (Raveh
et al., 1982), L5178Y mouse lymphoma cells (Gold et al., 1980) and Chinese
hamster ovary (CHO) cells (Krolewski et al., 1986). CPP was also shown to be a
strong mutagen in human diploid lymphoblast (Skopek et al., 1979; Crespi and
Thilly, 1984) and it transformed mammalian cells and caused sister chromatid
exchanges (Eisenstadt and Gold, 1978). CPP was also reported to induce
fibrosarcoma in CFW mice (Neal and Trieff, 1972).
In conclusion, CPP was highly mutagenic, when compared to BaP (Wood et
al., 1980), and was carcinogenic in mouse skin tumorigenicity assays with (Wood
et al., 1980; Cavalieri et al., 1981) and without (Raveh et al., 1982; Cavalieri et al.,
1981) subsequent promotion. In newborn mouse lung adenoma bioassay, CPP was
a strong inducer of malignant lung tumors and resulted in synergistic malignant
tumor induction with BaP (Busby et al., 1988). Although CPP was thought to be
less carcinogenic than BaP, based on mouse skin studies, the observed skin
cytotoxicity and inverse dose-tumorigenicity relationships at the doses of CPP
commonly used clouded the data (Cavalieri et al., 1981; Cavalieri et al., 1983). In
contrast, CPP exhibited five times more tumorigenic activity than BaP in the A/J
mouse lung adenoma system. Additionally, the high malignancy index of CPP in
the newborn mouse assay (Busby et al., 1988) and its potent effect in mixtures on
tumor multiplicity and metastases (Cavalieri et al., 1983) warrant its consideration
as a potent carcinogen.
2.1.4 Mutational spectra of CPP
CPP induces mutations in various systems. The spectrum of basepair
substitution mutations induced in lacI gene of a uvrB" strain of Escherichia coli by
CPPE as well as by baP-7,8-dihydrodiol-9,10-epoxide (BPDE) was determined.
Either BPDE or CPPE induced about 10% of nonsense mutations in all lacI gene
mutations, suggesting that basepair substitutions are a large fraction of the
mutational events caused by these species in this system. Both carcinogens
produced the major G:C--T:A and the minor A:T--+T:A transversions. One
potential mechanism for these induced transversion induction at G:C sites might
involve carcinogen binding to the exocyclic amino group of guanine in the template
strand followed by a rotation of the modified base around its glycosydic bond from
the anti to the syn conformation. Then, an imine tautomer of adenine could pair
with these modified bases (Eisenstadt et al., 1982).
In the most recent CPP-induced mutation report, four independent cultures
of a human cell line expressing cytochrome P450 1A1 (cell line MCL-15) were
treated with CPP, and mutants at the hypoxanthine phosphoribosyltransferase
(HPRT) locus were selected against 6-thioguanine (6TG). The mutations were
examined by the combination of high-fidelity polymerase chain reaction (hifi-PCR)
and denaturing gradient gel electrophoresis (DGGE). In detail, the third exon of the
HPRT gene was first amplified from 6TG-resistant cells using the hifi-PCR. Then,
the amplified fragment was analyzed by DGGE to separate mutant sequences from
the wild-type sequence. Finally, mutant bands were excised from the gel, amplified
using PCR and sequenced. Sixteen different mutations were identified and consisted
mostly of the G to C transversion and a single G deletion. Six mutations occurred
within a run of six guanines. The majority of transversions induced by CPP
involved a guanine or an adenine, which is similar to the data previously reported
for the racemic mixture of BaP in human TK6 cell line. This observation also
suggested that the mechanisms of mutation induced by CPP may be similar to those
induced by BaP (Keohavong et al., 1995), as it observed in the lacI gene of
Escherichia coli treated with CPPE or BPDE mentioned above (Eisenstadt et al.,
1982).
The mutational spectrum in Ki-ras oncogene from CPP-induced tumor in
strain A/J mice lung was also explored. Ki-ras codon 12 mutation analyses of the
DNA from tumors taken from CPP dose groups displayed the following mutations:
GGT-+CGT (50%); GGT-+GTT (15%); GGT-+TGT (25%); GGT-+GAT (10%).
Using this A/J mouse lung adenoma model, CPP is five times more tumorigenic
than BaP. This is different from the result that CPP was a considerably less potent
mouse skin tumorigen or tumor initiator when compared to that of BaP. Therefore,
it is suggested that the increased activity of CPP may be due to the unique induction
of the GGT-+CGT on Ki-ras codon 12 mutation (Nesnow et al., 1994). The related
results observed with another CP-PAH, benzo[i]aceanthyrlene (b[j]A), also sustained
this hypothesis (see below).
B[j]A is a demethylated analogue of 3-methylcholanthrene (3-MCA) with an
unsaturated cyclopenta ring. It produced 16 to 60 fold more A/J mouse lung tumors
at equivalent doses than did BaP, and it induced a similar mutational spectrum as
CPP did in A/J mouse lung tumors (Mass et al., 1993). The mutations induced by
B[j]A were GGT-+CGT (65%), GGT--+GTT (30%), and GGT--+TGT (4%). In
contrast, BaP induced GGT-+TGT (56%), GGT--GTT (25%), and GGT-+GAT
(19%) mutations. 3-MCA was shown to be activated primarily via bay-region diol
epoxide since its cyclopenta ring is saturated and not easily epoxidated (Yang et al.,
1990). In fact, 3-MCA induced similar mutational patterns in Ki-ras codon 12 of
mouse cells as BaP did (Chen and Herschman, 1989). Previous studies have also
been suggested that the cyclopenta ring of B[j]A could be activated (Nesnow et al.,
1988) and was the major site of DNA-adduct formation (Nesnow et al., 1991), even
thought B[j]A contains a bay-region. Therefore, the GGT-+CGT mutations
produced by B[j]A here were proposed to be the results of cyclopenta-ring derived
adducts (Mass et al., 1993). This conclusion is also consistent with the results
observed with CPP mentioned above (Nesnow et al., 1994).
2.2 Covalent adducts as dosimeters
People are exposed to chemicals from environmental, occupational and life-
style sources. It has been estimated that the majority of human cancers are
attributable to environmental factors such as contaminants in air and food, and
personal habits such as smoking and dietary patterns (Perera and Weinstein, 1982;
Basu and Saxena, 1978; Lijinsky and Ross, 1967; Baek et al., 1991; Higginson and
Muir, 1976). Therefore, one approach to understanding cancer from these sources
is to identify the carcinogens to which we are exposed and to categorize them in
terms of their relative carcinogenic risk. Clearly, determining if a compound is a
human carcinogen, studying it epidemiologically, and preventing exposure to it can
minimize cancer. In fact, more than 50 substances or mixtures have been identified
based on this system (Tomatis et al., 1989). Epidemiological studies have been
successful in cases where specific exposures to high concentrations of compounds
have been involved (e.g., workplace exposures). However, traditional
epidemiological techniques have certain limitations, such as their difficulty
investigating the individual contributions of single chemicals in highly complex
exposure situations (e.g., urban pollution). Therefore, this limitation has been one
of the stimuli for the recent development of "biomonitoring" or "molecular
dosimetry" techniques (Farmer, 1994).
Molecular dosimetry refers to the assessment of the internal dose of a toxic
compound by measurement of the extent of chemical interaction of the compound
with biological macromolecules, including proteins and nucleic acids. Such
evaluation takes into account individual differences in absorption, metabolism,
distribution, and excretion. Therefore, determination of the dose of active
compound that reaches the target site of action within the body permits one to
estimate the risk associated with the exposure.
The molecular dosimetry approach has been most extensively developed for
exposure to genotoxic carcinogens. These carcinogens have the common
characteristic of being able to react with DNA to form covalently bound products,
or adducts. In some cases, these compounds may be acting directly on DNA to
yield an adduct. In many other cases, a metabolic mechanism is required to convert
the chemical to a reactive species that can then interact with DNA. Adduct
formation is considerably site-selective within the DNA chain even for simple
alkylating agents such as methylating agents (Dolan et al., 1988). In addition,
adduct formation at specific sites in DNA is shown to cause the activation of
oncogenes (Zarbl et al., 1985) and may also result in suppression of tumor-
suppressor genes (Hsu et al., 1991; Bressac et al., 1991).
Adduct formation with carcinogens also occurs with proteins and it is not
considered to be as relevant to the carcinogenic processes as the formation of DNA
adducts. However, substantial emphasis has been placed on protein adducts, mainly
because of their availability and long lifetime as with hemoglobin.
Two kinds of mechanisms have been proposed to explain how
macromolecular interactions lead to neoplastic changes (Foulds, 1969) and may still
be valid today. Genetic mechanisms assume that neoplasia is due to the alteration
in the cell genome. Epigenetic mechanisms assume that neoplastic changes are
caused by a change in expression of the genetic compliment of a cell without
altering its genotype.
2.2.1 DNA adducts vs. protein adducts
The degree of binding of a carcinogen or its metabolite(s) to a given cellular
protein or DNA varies from one carcinogen to another. This could depend upon the
stability of the carcinogens or their metabolites and their chemical and physical
reactivity with these cellular macromolecules (Montesano, 1990).
Determination of the suitable target molecule for carcinogen exposure will
be based on the experimental investigation. The degree of binding of the adduct is
the primary consideration. The percentages of an oral dose of 15 chemical
carcinogens binding to rat hemoglobin vary more than 300-fold (Pereira and Chang,
1981). For instance, 4-aminobiphenyl bound to hemoglobin is a valuable marker
of exposure to this carcinogen from cigarette smoke (Bryant et al., 1987; Bryant et
al., 1988), but the binding of aflatoxin B1 (AFB1 ) to hemoglobin is some 50-fold
less efficient than to albumin after a single exposure to rats (Wild et al., 1988).
Instead, AFB1 -albumin adduct determination has offered important findings on
human exposure to this carcinogen and on the relationship between adduct levels
and intake of food contaminated with AFB 1 (Gan et al., 1988; Montesano, 1990;
Wild and Montesano, 1989).
The other parameter to consider is the stability of the adduct. For protein
adducts, this is determined primarily by the half-life of the protein. Hemoglobin has
a lifetime of approximately 125 days. Adduct measurements, therefore, should
provide information on cumulative past exposure. In contrast, albumin can provide
exposure information relevant to the past 2-3 months since it has a half-life of about
25 days. This assumes that the modified protein has the same half-life as the parent
molecule. In fact, it appears that hemoglobin has a longer half-life than 4-
aminobiphenyl-substituted hemoglobin (Green et al., 1984). No indication of
enzymatic repair is involved in protein adducts (cf. DNA adducts).
Lately, other non-blood proteins such as histones and collagen are being used
to investigate tissue-specific carcinogen-protein adduct formation (Groopman et al.,
1980; MacLeod et al., 1980; Skipper et al., 1994; Peng, 1993). Histones are small
positively-charged proteins that bind DNA. It has been estimated that the half lives
of mouse liver and brain histones are as much as 20% of the lifespan of a mouse.
Thus, investigating histones from a chemical target tissue offers a more realistic
assessment of exposure. Recent data has also suggested the role of histones in gene
regulation (Grunstein, 1992; Wolffe, 1992). Collagen is a structural protein of
extracellular matrix that consists of one or more domains having the conformation
of a collagen triplex helix. It comprises about one third of the total mass of protein
in vertebrates. Like histone, collagen also possesses a longer half-life in comparison
to albumin and hemoglobin and it can be tissue-specific (Skipper et al., 1994).
It is worth noting that the situation of patients undergoing chemotherapy may
provide an unique opportunity to evaluate some of these questions discussed above
if biological samples can be obtained without increasing the discomfort of the
patient. Generally, the patient is exposed to high and defined doses of drugs which
could allow dosimetry data to be established (Montesano, 1990).
The modification of DNA is generally recognized as an important step in the
carcinogenic process; therefore information on DNA adducts as biomarkers is
considered to have better predictive value than protein adducts. However, the
detection of the low levels of adduct in human cells (generally less than one
modification in 10 million normal deoxynucleosides) is technically demanding
(Montesano, 1990). Measurements can be made of DNA adducts in cells of
accessible tissues (e.g, white blood cells, biopsy, or autopsy samples). In addition,
another approach to monitoring DNA adducts takes advantage of the fact that
adducts are removed from cellular DNA and are excreted in urine (Shuker and
Farmer, 1992).
It is generally believed that DNA adducts result in mutations, which
ultimately lead to cancer. Several mechanisms have been proposed to rationalized
the mutations based on the results obtained from bulky mutagens/carcinogens.
These mechanisms can be classified into three categories: (1) a miscoding
mechanism in which the adduct is misinformational, (2) a noncoding mechanism in
which the adduct is noninformational, and (3) indirect mechanisms in which the
adducts may an intermediate in the formation of another lesion that induces
mutations such as an apurinic site (Loechler, 1989; Loechler et al., 1995).
2.2.2 Hemoglobin adducts of CPP
Since mouse and human microsomes exhibited similar CPP metabolic
profiles, the hemoglobin adducts induced by CPP in mice in vivo has been
investigated (Kwon, 1992). CPPE has been shown to be the derivative that binds
to mouse hemoglobin using fluorescence-line narrowing spectroscopy. The major
hemoglobin adduct formed by the single dose of CPP was identified to be histidine
substituted. In experiments with multiple doses of CPP (every three days for 14
days), this adduct was not detected. Instead, a labile ester CPPE-derived adduct was
obtained by the presence of dihydrodiol.
2.2.3 Methods for measuring carcinogen-DNA adducts
The analytical techniques used in human biomonitoring through DNA
adducts include physicochemical methods, immunochemical methods, 32P-
postlabelling method, and 35S-postlabelling method.
2.2.3.1 Physicochemical Techniques
DNA adducts can be analyzed by GC and HPLC in conjunction with
different detection techniques. For example, GC with mass spectrometry (GC/MS)
may be the most commonly used approach to detect and identify carcinogen-DNA
adducts and has a resolving power of I adduct per 107 nucleotides. The application
of GC/MS to human biomonitoring, however, has been limited mostly to the
analysis of DNA repair products in urine. HPLC with electrochemical conductance
detection (HPLC/ECD or HPLC/EC) has been used to detect 8-hydroxy-2'-
deoxyguanosine in urine. This analysis is also adopted generally to monitor
oxidative damage of DNA caused by endogenous oxidants (Van Welie et al., 1992).
In addition, HPLC with fluorescence detection was employed to measure the low
levels of BaP-DNA adducts (Farmer, 1994).
Other techniques used for urinalysis include HPLC-fluorescence, tandem
mass spectrometry (MS/MS), GC/MS, and immunochemical procedures, in addition
to HPLC/EC. GC/MS and enzyme-linked immunosorbent assay (ELISA) followed
by immunoaffinity purification could also quantify adducts effectively in urinalysis
(Prevost et al., 1990; Friesen et al., 1991; Farmer, 1994; Prevost et al., 1993).
N-3-alkyladenines and N-7-alkylguanines are two unstable DNA adducts in
nucleic acid and undergo spontaneous depurination. Investigation of these products
in urine, thus, provide a noninvasive and convenient way to monitor recent DNA
damage caused by alkylating carcinogens (Marnett and Burcham, 1993). For
example, N-7-methylguanine has been detected in urine by GC-MS, GC-flame
ionization detection (GC/FID) and GC-nitrogen phosphorus detection (GC/NPD).
In rats, the levels of urinary N-7-methylguanine was used to monitor exposure to
certain N-nitroso compounds, nitrosatable drugs such as aminopyrine and
cimetidine, and alkylating agents such as methyl methanesulfonate (Shuker et al.,
1984; Farmer et al., 1986; Bailey et al., 1987; Farmer, 1994; Van Welie et al.,
1992). In humans, the quantitation of alkylating products derived from methylating
agents, ethylating agents, and AFB 1 has also been subjected to urinalysis. Most
notedly, the concentration of urinary aflatoxin B 1 -N7-guanine adducts were recently
demonstrated to be associated with the risk of developing hepatocellular carcinoma
in a case-control study in China (Ross et al., 1992).
The use of fluorescence assays for the detection of DNA adducts is
particularly applicable to exposure to aflatoxin and PAHs (Farmer, 1994). These
means as well as mass spectrometry generally require hydrolysis of the DNA
followed by chromatographic or immunoaffinity purification of the adduct or one
of its hydrolysis products. For instance, synchronous fluorescence spectrometry
(SFS) has been used to detect BaP tetrol derived from acid hydrolysis of BaP-DNA
adducts, and the sensitivity of this technique is about 1 adduct per 107 nucleotides
that is similar to GC/MS measurements (Weston et al., 1989; Vahakangas et al.,
1985). One disadvantage of this technique is that the resolving power of SFS is
often not sufficient to determine single compounds of interest in complex mixtures.
However, specificity may be enhanced by organic extraction and HPLC before
quantitation (HPLC/SFS) (Weston et al., 1989; Farmer, 1994; dell'Omo and
Lauwerys, 1993).
The newly developed fluorescence line-narrowing (FLN) techniques are also
being used for PAH-DNA adduct analysis (Jeffrey, 1991; Jankowiak et al., 1988).
This laser-induced cryogenic (77 or 4.2 OK) FLN spectroscopy together with
fluorescence quenching is a highly specific approach for the study of carcinogen-
DNA adducts and has been suggested as a tool for human biomonitoring (Jankowiak
and Small, 1991). The principles of FLN for analysis of DNA- and globin-PAH
adducts have been reviewed (Personov, 1983; Jankowiak and Small, 1989). Recent
applications of FLN to the analysis of macromolecular and nucleoside adducts
include the investigation of stereoisomeric DNA adducts derived from BPDE (Lu
et al., 1991; Jankowiak et al., 1990b; Jankowiak and Small, 1989), elucidation of
different DNA binding configurations for stereoisomeric BPDE adducts with the aid
of fluorescence quenching (Lu et al., 1991; Jankowiak et al., 1990b), conformational
studies of in vivo BaP radical cation pathway (Zamzow et al., 1989; Rogan et al.,
1990), human hemoglobin adduct formation by BaP (Jankowiak et al., 1990a), and
human lung DNA and histone adducts from BaP (Jankowiak and Small, 1991;
Ozbal et al., 1995). The disadvantages of FLN as well as other fluorescence assays
are that the number of adducts that can be analyzed is limited and that cross-
reactivity with other fluorophores, leading to difficulties in quantitation, is possible
(Farmer, 1994). In one recent study, FLN was able to detect 5 BaP adducts per 108
bases using 1 ug of human lung DNA (Ozbal et al., 1995).
2.2.3.2 Immunochemical Techniques
Immunoassays use mono- and poly- clonal antibodies to detect DNA adducts.
The basic principle of an immunoassay is the coupling of the antigen or antibody
to a fluorescent dye or an enzyme. Then, quantification of substrate conversion by
the amount of bound fluorescence or the enzyme is a measure of the amount of
antigen present. At least 20 specific polyclonal and monoclonal antibodies against
carcinogen-DNA adducts are available (Santella, 1988; Anon, 1989). Antibodies
are employed in a variety of competitive and noncompetitive, single- or multistep
assays, such as radioimmunoassay (RIA), enzyme-linked immunosorbent assay
(ELISA), ultrasensitive enzymatic radioassay (USERIA), and the immuno-slot blot
technique (ISB). The sensitivities of these techniques may reach 1 adduct per 108
normal nucleotides, but the quantitative demands for sample size may be relatively
large, for example, up to 500ug DNA. Nevertheless, an advantage of utilizing
immunoassays to analyze DNA adducts is that they are more applicable for routine
and relatively low-cost screening of large human populations (Farmer, 1994).
The best known problem associated with the operation of immunoassays is
cross-reactivity of the antibody with adducts of chemically-related composition.
This property, on the other hand, serves another role as the basis for immunoaffinity
chromatography because of the broad-spectrum of antibodies. This affinity
chromatography is commonly adopted to be the preliminary purification step for
adducts prior to their examination by physicochemical or postlabelling techniques
(Farmer, 1994).
BaP-DNA adducts have been detected using ELISA and USERIA (Perera et
al., 1982; Shamsuddin et al., 1985; Van Welie et al., 1992; Perera et al., 1986).
Other carcinogens where immunological detection of their DNA adducts have been
used include aflatoxin B1, 4-aminobiphenyl, 2-actetylaminofluorene, cis-
diamminedichloroplatinum (II) (cisplatin), and certain alkylating agents (Farmer,
1994).
2.2.3.3 32 P-Postlabelling Technique
Currently, the 32P-postlabelling system is the most sensitive technique for
determining DNA adducts (Gupta, 1985; Gupta et al., 1982). Although it is not
adduct-specific, an extreme sensitivity is achieved. At best, it can reach the
detection of I adduct per 1010-10 11 unmodified nucleotides, or -1 adduct per cell.
It is particularly useful for the measurement of adducts derived from exposure to
complex mixtures of unknown carcinogens. Generally, purified DNA (1 to 10 Oug)
is subjected to enzymatic digestion and forms deoxyribonucleotide-3'-
monophosphates followed by isolating. A subsequent 32 P transfer from adenosine
[r- 32P]triphosphate to the 5' position is catalyzed by T4 polynucleotide kinase to
result in deoxyribonucleotide-3',5'-[5'- 32P]biphosphates. Then, radiolabelled
adducts are isolated by multi-directional TLC to produce a fingerprint of the
modified nucleotides. Finally, adducts are detected and quantified using
autoradiography. Sensitivity may be improved by extracting the digested DNA
adducts with 1-butanol before labelling and by removing the hydrophobic adducts.
In some cases, HPLC was adopted to substitute for TLC (Beach and Gupta, 1992;
Farmer, 1994; Van Welie et al., 1992).
The 32P-postlabelling assay has been used to detect DNA adducts in several
human tissue and blood samples in terms of quantifying total adduct levels. It has
been applied to mixed exposure situations such as smoking (Randerath et al., 1986;
Everson et al., 1986; Dunn and Stich, 1986), foundry work (Phillips et al., 1988;
Hemminki et al., 1988), or coke plant operations (Hemminki et al., 1990). Many
classes of chemical carcinogen have also been monitored by the 32P-postlabelling
method, and they include PAHs, nitroPAHs, aromatic amines, alkylating agents,
mycotoxins, chemotherapeutic agents, and active oxygen radical generators
(Randerath et al., 1985).
2.2.3.4 35S-Postlabelling Technique
Although 32 P-postlabelling is a sensitive technique for DNA adduct detect
ion in tissue DNA samples and widely applicable to compounds of unknown
structure (Reddy et al., 1984; Randerath et al., 1989), accurate quantitation of
adducts levels is complex because the recovery of adducted nucleotide 3'-
monophosphates and their kinase substrate activities vary substantially. Therefor
e, its application to specific exposure cased has been restrict.
A new postlabelling technique, 35S-postlabelling, was developed for
carcinogen-DNA adducts and attempted to address some problems that inherit fro
m aforementioned techniques. Briefly, DNA is digested enzymatically and adduc
ted nucleosides are separated from unmodified nucleosides by either HPLC or
immunoaffinity purification. Subsequently, adducted nucleosides are subjected to
acylation with t-butoxycarbonyl-L-[ 35S]methionine, N-hydroxysuccinimidyl ester
(35 S-TBM-NHS) for identification and quantification. Alternatively, adducted
nucleosides can be acylated as a mixture, after that total adduct levels can also be
determined by HPLC separation, and in parallel, specific carcinogen adducts can be
determined by immunoaffinity purification.
35S-postlabelling was designed to be sensitive, specific, quantitative, and
applicable to carcinogens representing diverse chemical classes. In fact, studies
have shown that this technique has the detection limit on the order of tenths of
attomoles (Sheabar et al., 1994b). In addition, a linear correlation was obtained
between the amounts of N-(2'-deoxyguanosin-8-yl)-4-aminobiphenyl introduced t
o the reaction and the total amount of TBM-acylated products formed (Sheabar e
t al., 1994a). Taken together, 35S-postlabelling has a potential as an analytical
method for the detection and quantification of DNA adducts in human target tiss
ues or accessible surrogate cells.
2.2.4 Covalent modification of DNA
The chemistry of carcinogen-DNA interaction is not fully understood, eve
n though a few aspects of reactivity towards different nucleophiles have been
summarized (Swain and Scott, 1953; Ross, 1962; Lawley, 1976; Ehrenberg and
Osterman-Golkar, 1980). Most of these reviews regarding these chemical
interactions seem to apply well to simple alkylating agents.
Lawley and Brookes used methylating agents to model the more complex
reactions of antitumor alkylating agents, and defined much of the basic chemistry
of nucleic acid alkylation (Lawley and Brookes, 1963). This is relatively comple
x because the sites of reaction on some nucleic acid components vary depending on
whether the target molecule is a base, a nucleoside, a component of RNA or a
component of DNA. For instance, the 3-position of adenine is the primary site f
or alkylation in double stranded DNA. For adenosine or adenine residues in RN
A or single stranded DNA, however, the principal site is the 1-position. The 7-
position of guanine is the major site for alkylation in guanine nucleosides, RNA,
and DNA. By the mid-1960's, the most susceptible site for alkylation in DNA w
as showed to be N-7 of guanine residues in the major groove of the helix follow
ed in decreasing order by N-3 of adenine, N-1 of adenine, N-3 of cytosine and N-7
of adenine residues.
Another complexity of alkylation chemistry is that ring nitrogen alkylated
products are relatively unstable. For example, at neutral and acid pH, the glycosi
dic bond in 7-alkylguanine nucleotides and the 3- and 7-alkyladenine nucleotides
in DNA is easily hydrolyzed. At alkaline pH, however, 7-alkyldeoxyguanosines are
opened in the imidazole ring to give triaminopyrimidine derivatives and 1-
alkyldeoxyadenosines undergo a rearrangement to 6-alkylaminopurine
deoxyribonucleosides (Moschel et al., 1979; Qian and Dipple, 1995; Macon and
Wolfenden, 1968). Thus, biological effects of these ring nitrogen-substituted
products can be influenced by chemical transformations secondary to the initial
DNA alkylation. Notably, the exocylcic amino groups are not effectively targete
d by the alkylating agents (Hemminki, 1983; Dipple, 1995).
The history of chemical carcinogenesis is closely related to aromatic amin
es, a major class of arylaminating agents, which were recognized as causes of
bladder cancer in dye workers. For most of aromatic amines, N-hydroxylation a
nd esterification have been considered necessary for their carcinogenicity. Other
carcinogenic arylaminating agents include aminoazo dyes, the nitroaromatics, and
the heterocyclic aromatic amines found in trace amounts in cooked meats and fis
h (Hemminki, 1983). Although the site of substitution on nucleosides by the
arylaminating agents in the major product varies, it seems initially that the
substituted sites on deoxyribonucleosides form a pattern that is very different fro
m that displayed by the alkylating agents. The C-8 atom and the exocylcic amin
o groups of the purine nucleosides, especially deoxyguanosine, are the major targ
ets for the arylaminating agents. In contrast, these sites are unaffected by alkylat
ing agents (Dipple, 1995).
A recent study has suggested that the aromatic amine adducts modified at C-
8 of deoxyguanosine arise from a 7-substituted deoxyguanosine precursor
(Humphreys et al., 1992). This evidence implies that the 7-position of
deoxyguanosine residues may be a common reactive center for both the alkylatin
g and arylaminating agents.
Carcinogens that transfer an aralkyl group to DNA include the large grou
p of PAHs and those nitroaromatics that are activated through the diol epoxide
mechanism. The reactions of the hydrocarbon diol epoxides with DNA result
primarily in modification of the exocyclic amino group of deoxyguanosine and
deoxyadenosine residues (Hemminki, 1983; Dipple, 1995).
The sites of reaction of each of the three categories of agent discussed ab
ove, including alkylating, arylaminating, and aralkylating agents, are summarized
in Figure 2.4.
2.2.4.1 Nucleic acid adducts of PAHs
The studies concerning nucleic acid adducts are few as compared to
carcinogenicity bioassays and metabolic studies with PAHs. Two diol epoxides of
benz[a]anthracene, 3,4-diol-1,2-epoxide, which possesses the epoxide group adjacent
to the bay-region and 8,9-diol-10,11-epoxide, which is a non-bay region diol
epoxide, were reacted with DNA in aqueous solution in vitro. Then, DNA was
digested enzymatically and the adducts were analyzed by HPLC. The major
adducts, formed by both diol epoxides, were modified at N2 position of
deoxyguanosine (Hemminki et al., 1980). This type of adduct has also been
observed in vivo after dosing benzo[a]anthracene (Hemminki, 1983).
Nucleic acid adducts formed in vitro by BaP-7,8-diol-9,10-epoxide (BPDE),
a bay-region diol epoxide, were characterized the following substitution sites: 90%
of N2-G, 5% of N6-A, and 1% at possible N4-C (Straub et al., 1977; Meehan et al.,
1977). Using the (-) isomer of anti-BaP-diolepoxide, the N7-G and O6-G
derivatives were also detected and suggested, respectively (Osborne et al., 1981).
In contrast, no N7 or 06-G adduct was detected in DNA from BaP-treated
mammalian cells. This might be due to the fact that (+) anti-BaP-diolepoxide was
the major metabolite in cells. Few authors have found that BaP-diolepoxide may
also react with DNA and form phosphotriesters (Koreeda et al., 1976; Gamper et
al., 1977). N2-G adducts were also identified in several in vivo samples, such as
cultured cells (Feldman et al., 1978), tissue cultures (Atrup et al., 1978; Harris et
al., 1979), and mouse skin (Koreeda et al., 1978), after administration of BaP
(Hemminki, 1983).
One-electron oxidation with formation of radical cations is another major
mechanism of PAH activation leading to carcinogenesis (Cavalieri and Rogan, 1985;
Cavalieri and Rogan, 1992). Cavalieri and Rogan have suggested that PAHs are
predominantly activated by either the diolepoxide pathway or the one-electron
oxidation pathway or by both (Cavalieri and Rogan, 1992). Structure determination
of biologically-formed PAH adducts provides evidence about the mechanism of
activation. Identification and quantitation of the DNA adducts formed by 3-MCA-
induced rat liver microsomes demonstrated that BaP (Moncada et al., 1991) and
DMBA (RamaKrishna et al., 1992a) are activated primarily by one-electron
oxidation to form adducts that are lost by depurination. In the case of BaP, the
depurination adducts formed by one-electron oxidation, 8-(benzo[a]pyren-6-
yl)guanine (BaP-6-C8G), BaP-6-N7G, and BaP-6-N7A, constitute 80% of all the
adducts, whereas the depurination adduct formed by BPDE, BPDE-10-N7A,
accounts for only 0.5%. The major stable DNA adducts, or BPDE-10-N2G,
accounts for only 15% of the adducts. Recent results demonstrate that in mouse
skin, BaP-DNA adducts (Rogan et al., 1993) and DMBA-DNA adducts (Devanesan
et al., 1993) are also predominantly formed via one-electron oxidation.
The structural and functional aspects of DNA modification by BaP at N2 of
G has been investigated and the data demonstrated that BaP is located in the narrow
groove of DNA (Grunberger and Weinstein, 1979). In contrast to N2-G adducts,
BaP-N6-A adducts appear to localize to the major groove of DNA (Jeffrey et al.,
1979).
Some halogenated derivatives of PAHs have been used as model compounds
to study nucleic acid binding of PAHs. The correlations between DNA binding and
carcinogenesis of 7-bromomethylbenz[a]anthracene and 7-bromomethyl-12-
methylbenz[a]anthracene, which form their reactive carbonium ions spontaneously,
have been investigated. These compounds produced similar major products, N2-G
and N6-A adducts, in DNA in vitro (Rayman and Dipple, 1973). However, the
level of binding is lower with 7-bromomethyl-12-methylbenz[a]anthracene, which
is more carcinogenic than 7-bromomethylbenz[a]anthracene. This contradiction
between carcinogenic potency and the level of DNA binding is not due to the
differential biological stabilities of the adducts (Dipple and Schultz, 1979). The in
vitro modification positions by 7-bromomethylbenz[a]anthracene depend on the
solvent used. In aprotic solvents a higher preference towards ring nitrogens is noted
as compared to exocyclic nitrogens in aqueous solvents (Dipple et al., 1971; Shapiro
and Shiuey, 1976). In 50% dioxane, 6-chloromethylbenzo[a]pyrene reacted with
guanosine and formed N7- and N2- aralkyl derivatives as major and minor products,
respectively. In similar conditions, the products with adenosine were N-1 (major)
and N6 (minor) derivatives, and with cytidine were N3 (major) and N4 (minor)
derivatives (Hemminki, 1983; Royer et al., 1979).
In summary, the reactions of the PAH diol epoxides with DNA result
predominately in modification of the exocyclic amino groups of dG and dA [minor
products at N7 of dG (Cheh A.M. et al., 1993) and amino group of dC (Chadha et
al., 1989) have been characterized in isolated cases]. The distribution of PAHs over
the target sites varies considerably with the structure of the PAHs. Diol epoxides
derived from planar PAHs react primarily at the amino group of dG in DNA.
However, diol epoxides derived from PAHs that are substantially distorted from
planarity, by a substituent methyl group in the bay region or by the presence of a
fjord region, react mainly at the amino groups of both dG and dA (Dipple, 1994).
As mentioned above, some PAHs also react with DNA extensively through one-
electron oxidation process (Rogan et al., 1993; Dipple, 1995).
2.3 Intercalation vs covalent binding to DNA
In addition to covalent binding of electrophilic metabolites of PAHs, the
formation of non-covalent interaction complexes of PAHs and DNA was also
studied (Geacintov et al., 1984). Generally, when the reaction rates of PAH diol
epoxides with DNA dominate over those in the external aqueous solution, the level
of covalent binding is independent of the intercalative binding, which precedes the
covalent binding. Whereas, if DNA does not enhance or catalyze the rates of
reaction of diol epoxides, such as in high salt buffers, the level of covalent binding
to DNA can be predicted to be directly proportional to the intercalative binding.
This relationship also applies to the condition when there are efficient competitive
reaction pathways in the solution external to DNA. In either of these two cases, the
ability of a diol epoxide to intercalate DNA prior to covalent binding can be a
critical factor of estimating the biological activity of its parent molecule (Geacintov,
1986).
The salt concentration in a cell is approximately 150 mM. This should be
sufficient for a given diol epoxide to form an intercalative complex with DNA prior
to covalent binding (Geacintov et al., 1984). Additionally, enzymes, lipoproteins,
and cellular nucleophiles may also compete with DNA to react with PAH diol
epoxides. One study has shown that the mutagenicity and tumorigenicity of 1-alkyl
derivatives of BaP depend strongly on their ability of intercalating with DNA
(Harvey et al., 1985). As the bulkiness of the substituent increases (methyl, ethyl,
isopropyl, and tert-isobutyl) a significant drop in the biological activities were
observed. This drop was not attributable to differences in metabolic activation. In
vitro physical binding experiments were consistent with the notion that bulky inert
side groups inhibit intercalation of PAHs to DNA (Geacintov, 1986; Michaud et al.,
1983).
2.4 Sulfonation in chemical carcinogenesis
Sulfonation is used here to replace the commonly used but less precise term
sulfation for the sulfotransferase-catalyzed transfer of the sulfo group (-SO 3H, -S03
) (Benkovic and Hevey, 1970) from the cofactor 3'-phosphoadenosine-5'-
phosphosulfate (PAPS) (Robbins and Lipmann, 1957) to the oxygen and nitrogen
atoms of -C-OH, -N-OH, and -NH groups in foreign and physiological substrates
(Mulder and Jakoby, 1990). The products of these transfers are sulfuric acid esters
(also called sulfates, or sulfooxy- or sulfonyloxy- derivatives) or sulfamides
(sulfamates). Sulfonation has been used to describe the conjugation of substrates
by sulfotransferase and PAPS (Miller and Surh, 1995).
O- and N-sulfonation produce many water-stable sulfuric acid esters and
amides, such as heparin and estrogen sulfates, endogenously (Mulder and Jakoby,
1990). Many foreign compounds have also shown to be detoxified in mammals by
metabolism to sulfates. These sulfates are believed to pass across membranes easily
and then are excreted in urine (Williams, 1959). Recently, chemical carcinogens
have also been investigated for sulfonation. For several cases these agents are
activated to form sulfuric acid esters or covalently react with cellular
macromolecules to from adducts. Detoxification of chemical carcinogens by the
sulfonation pathway was also observed (Miller and Surh, 1995).
Evidence for formation of sulfuric acid esters is mainly obtained from the
isolation and characterization of cellular molecule adducts in reactions that were
dependent on PAPS and showed inhibition of sulfotransferase activities by
pentachlorophenol (PCP), 2,6-dichloro-4-nitrophenol (DCNP), or
dehydroepiandrosteone (DHEA). One direct evidence was obtained by isolating the
unstable sulfuric acid esters of 7-hydroxymethylbenz[a]anthracene from medium of
treated cells (Watabe et al., 1986). PCP and DCNP are inhibitors of the phenol
sulfotransferases, and DHEA is a competitive substrate of the hydroxy-steroid
sulfotransferases.
2.4.1 Metabolic activation of PAHs by sulfonation
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Figure 2.4 Sites of substitution of DNA bases by genotoxic carcinogens.
Sites modified by alkylating agents are marked by the numerbal I, those
modified by arylaminating agents by a II and those modified by
aralkylating agents by a III. Since it has been suggested that C-8
substituted arylamino adducts may have arisen from N-7 substituted
precursors (Humphreys et al., 1992), the arylaminating agents are listed
parenthetically at the 7-position of the purines.
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3. Structure of the most abundant DNA adduct formed by
cyclopenta[cd]pyrene epoxide
3.1 Introduction
The resulting 3,4-epoxide of CPP (Figure 3.1) is often considered to be the
ultimate carcinogen, though evidence for diol epoxides as reactive electrophiles has
also been presented (Sahali et al., 1992; Kwon et al., 1992). The principal adducts
formed by CPPE with DNA, both in vivo and in vitro, have been characterized as
products of reaction with guanine (Nesnow et al., 1994; Beach et al., 1993; Beach
and Gupta, 1994). Structures of the guanine adducts are commonly thought to be
the 4-hydroxy-3-(N2-guanyl)dihydroCPP structures shown in Figure 3.1. The
present study was undertaken to provide detailed information regarding the regio-
and stereo-chemistry of guanine adduct formation by CPPE. This information is
expected to be helpful in understanding the mechanisms of CPP-induced
genotoxicity.
3.2 Materials and Methods
Chemicals
CPP and [G- 3H]CPP were prepared by Midwest Research Institute (Kansas
City, MO) and Chemsyn Science Laboratory (Lenexa, KS), respectively, and
obtained from the National Cancer Institute Chemical Carcinogen Repository. CPPE
was prepared from CPP by oxidation with dimethyldioxirane in methylene chloride
as described previously (Kwon et al., 1992). CPP-3,4-diols were prepared by acid
hydrolysis of CPPE followed by HPLC to isolate the trans- and cis- isomers (Sahali
et al., 1992). Calf thymus DNA containing [8- H]guanine or [1',2'-
3H]deoxyguanosine was prepared with the Nick Translation System of Promega
(Madison, WI), using the supplier's protocol. [3H]dGTPs used for the Nick
Translation were the products of Amersham Life Science (Arlington Heights, IL).
DNAse I (from bovine pancreas) was purchased from Sigma Chemical Co. (St.
Louis, MO) and spleen exonuclease (calf), snake venom exonuclease (Crotalus
durissus), and alkaline phosphatase (calf intestine) were purchased from Boehringer
Mannheim Biochemicals (Indianapolis, IN). Partisil 40 ODS-3 bulk
chromatography medium was obtained from Whatman Labsales (Hillsboro, OR).
All other chemicals and solvents used were reagent grade.
Instrumentation
Fast atom bombardment mass spectra were obtained by the spectroscopy
facility of the Chemistry Department at M.I.T. using a Finnigan MAT system 8200
with a Xe+ gun operated at 8 kV. Samples were prepared in a matrix of 3-
nitrobenzyl alcohol. Electrospray ionization mass spectra were acquired with a
Finnigan TSQ 7000. Nitrogen was used as sheath (80 psi) and auxillary (20 psi) gas.
A potential of 4.5 kV was applied to the ESI needle. The metal capillary was
maintained at 220 oC. Mass spectrometer parameters were optimized to obtain
maximum sensitivity without sacrificing unit resolution. Tube lens and capillary
voltages were voltages were optimized for maximum response at m/z 510. 1H-NMR
spectra were recorded using a Bruker AM-400 spectrometer. A Hewlett-Packard
HP1090 chromatograph equipped with diode-array detector was used for analytical
and preparative HPLC. Columns were Nucleosil C18 from Alltech Associates, Inc.
(Deerfield, IL) and had the dimensions 4.6 x 250 mm for analytical separations and
7.8 x 250 mm for preparative work; flow rates were 1 and 3 mL/min, respectively.
The solvent program was 50% CH 3OH in H20 for 5 min, followed by a linear
gradient to 80% CH3 OH at 55 min and to 100% CH 3 OH at 60 min.
Preparation of Adducts
Deoxyguanosine (500 mg) was dissolved in Tris-HCI buffer (0.05 M, pH 7.4,
250 mL) at 37 OC. To this was added, with vigorous stirring, a solution of CPPE
in DMSO (5 mL). The CPPE was prepared by epoxidation of 50 mg of CPP and
used immediately thereafter. Reaction was allowed to proceed for 2 hrs before
isolation of the adducts. The entire reaction mixture was applied to a column of
Partisil 40 ODS-3 (25 g) packed in methanol and equilibrated with H2 0 prior to
use. Elution with 10% CH3OH in H2 0 removed unreacted deoxyguanosine. Two
fractions with characteristic pyrene absorption spectrum were obtained by elution
with 60% and 70% CH3OH in H2 0, respectively. These two fractions were
combined and evaporated to dryness. The residue was partitioned between H2 0 and
benzene and the benzene fraction was discarded. The aqueous phase was then
extracted with ethyl acetate. Adducts were isolated from the ethyl acetate phase by
HPLC using conditions described above. An additional, smaller amount of adducts
was also isolated from the aqueous phase by HPLC.
DNA adducts were obtained by treating calf thymus DNA (1 mg/mL) in
Tris-HCl buffer (0.05 M, pH 7.4) with CPPE (20 nmol/mg DNA, based on amount
of CPP used) at 37 'C. After 2 hr the reaction was terminated by extraction with
ethyl acetate and the DNA was precipitated with ice-cold 95% ethanol. Precipitated
DNA was rinsed successively with 75% ethanol, 100% ethanol, acetone and diethyl
ether. DNA was redissolved in Tris-HCI buffer (0.04 M, pH 8.5) containing 10
mM MgCl2 at 0.5-1 mg/mL and digested with DNAse I (200 U/mg DNA), spleen
exonuclease (0.01 U/mg), snake venom exonuclease (0.5 U/mg), and alkaline
phosphatase (10 U/mg) at 37 OC for 3 hr. Adducts were extracted from the aqueous
phase with CHCl 3/n-propanol (7:3 v/v).
3.3 Results
Reaction of [3H]-CPPE with DNA under the conditions used in this study
resulted in a level of DNA base modification of one adduct per 15,000 nucleotides.
This level of binding is about six-fold lower than that reported by others (Beach et
al., 1993), but the ratio of CPPE:DNA was at least 20-fold smaller. Our results are
thus comparable and also suggest that adduct formation is more efficient at lower
CPPE:DNA ratios. Dependency of adduct yield in this manner has been observed
and discussed previously in the reactions of PAH metabolites (Geacintov, 1986) as
well as aflatoxin B1 epoxide (Raney et al., 1990) with DNA, and has been ascribed
to a mechanism in which intercalation of the carcinogen precedes covalent bond
formation.
HPLC analysis of the enzymatic digest of [3H]-CPPE-adducted DNA is
illustrated in Figure 3.2. Four peaks of radioactivity were observed, not including
the early peak at 4-6 min. This more polar material may include products such as
phosphate adducts; in any case, it was not investigated further. Two minor peaks,
with retention times corresponding to trans- and cis-CPP 3,4-diol, were present in
the chromatogram. The presence of diols in the digest is likely the result of
incomplete extraction of the reaction mixture. The remaining two peaks (F1 and
F2) were considered likely to be adducts. To test this assumption, [3H]-guanine was
incorporated into DNA and the DNA was reacted with nonradioactive CPPE. Only
the two peaks of radioactivity corresponding to F1 and F2 were observed in the
HPLC analysis of the enzyme digest, as shown in Figure 3.3. This result is
consistent with the two major peaks representing adducts of guanine, as expected,
and the two minor peaks being diols.
Greater quantities of the putative adducts were required for spectrochemical
characterization than could be obtained through the reaction of CPPE with DNA.
We thus attempted to obtain the same adducts by reaction of CPPE with
deoxyguanosine. This reaction yielded a complex mixture of products as detected
by absorbance at 275 and 342 nm, including two very closely eluting peaks with
essentially the same retention time as that of F2. These two peaks separated cleanly
from the large excess of cis-diol that eluted just after them.
Several procedures were attempted in an effort to purify micromole amounts
of the two UV peaks corresponding to F2. Ultimately, a combination of low
resolution ODS column chromatography to remove deoxyguanosine, benzene
extraction to remove the least polar impurities including unreacted CPP and the 4-
ketone, extraction of the adducts and diols as well as some other impurities into
ethyl acetate, and repeated semi-preparative HPLC proved satisfactory and each
compound was obtained essentially free of the other. These are now designated F2a
and F2b.
FAB-MS analysis of both F2a and F2b gave the expected molecular weight
for a product formed by alkylation of dG by CPPE (MH+ = 510, MNa+ = 532) as
well as a fragment ion at m/z 394. ESI-MS similarly yielded molecular and sodium
adduct ions at m/z 510 and 532, respectively. Fragmentation by cleavage of the N9-
Cl' bond with retention of charge by the guanine (m/z 394) was also observed in
ESI-MS, and yielded the base peak in this case. This distinctive fragmentation
pathway has been observed previously in the FAB (Annan et al., 1990) as well as
electrospray (Chaudhary et al., 1995) mass spectra of 2'-deoxyribonucleosides.
We were unable to obtain adequate separation of diol from other material in
the Fl- trans-diol region of the chromatogram of CPPE-deoxyguanosine adducts.
UV spectral analysis indicated that this region may have contained at least one
adduct since spectra with a characteristic increase in absorbance at 250-270 nm were
observed on the leading edge of the trans-diol peak. Material eluting in this region
of the chromatogram was collected for ESI-MS analysis on the premise that if an
adduct molecular ion could be detected in the mixture, then a mass spectrum could
be obtained by tandem MS. Good spectra were in fact recorded without resorting
to tandem MS, since the contaminating dihyrodiol did not undergo significant
ionization under ESI conditions. Ions at m/z 510 (MH), 532 (MNa+), and 394 were
the most abundant ions in the spectra, which resembled the spectra of the cis
adducts very closely.
The two adducts, F2a and F2b gave 1H spectra which were essentially
identical indicating that the two compounds were diastereomers arising from the two
enantiomers of CPPE reacting in the same manner with deoxyguanosine. Chemical
shifts and coupling constants are listed in Table 3.1. The three structural features
of the adducts that needed to be defined were (1) the stereochemistry of opening of
the epoxide ring of the CPPE, (2) the linkage site on deoxyguanosine, and (3) the
linkage site on the CPP moiety. No attempt was made to assign the absolute
configurations of the CPP moiety in the diastereomers. NMR studies on one
diastereomer were carried out in a DMSO-d 6 solution containing a small amount of
H20 which lead to rapid exchange of OH protons with the HDO signal. The other
diastereomer was exhaustively dried prior to dissolution in high purity DMSO-d 6
leading to the OH signals being in slow exchange so that coupling to vicinal carbon-
bound protons could be observed.
Signals for the protons on the CPP nucleus could be assigned on the basis
of observable couplings. Protons H6, H7, and H8 represent an AMX system in
which H7 is a doublet of doublets due to coupling to vicinal protons H6 and H8;
the coupling constants to the two protons differ only slightly such that H7 appeared
as a triplet. H6 and H8 show long range coupling to each other. The signal for H5
is a singlet. H9 and H10 are isochronous due to the high degree of symmetry in the
K region of the molecule. On the other hand, the signals for H1 and H2 are
significantly separated from one another and appear as doublets (J = 7.7 Hz). H3
and H4 have similar but non-identical chemical shifts. One of them is a doublet of
doublets due to coupling to the other one and also to the amino proton. Both
coupling constants are -7 Hz causing the signal to appear as a triplet. The other
CH appears as a doublet (J = 7.7 Hz) under conditions of rapid proton exchange of
the hydroxyl group but under more anhydrous conditions becomes an approximate
triplet (JCH-OH = 6.3 Hz).
The stereochemistry of ring opening was assigned as cis on the basis of the
7.7 Hz vicinal coupling constant. In five-membered rings with a high degree of
planarity, cis protons have a low torsional angle and show substantial coupling
whereas trans protons have a torsional angle near 900 and have minimal coupling.
The cis and trans 3-methoxy-4-hydroxy derivatives of CPP arising form
methanolysis of CPPE show vicinal coupling constants of 6.0 and 1.7 Hz,
respectively.
Assignments of the CH-N and CH-O as H3 and H4, respectively, were made
on the basis of long-range couplings to H2 and H5. Resolution enhancement of the
doublet assigned to H2 by Gaussian multiplication revealed additional long-range
coupling (1.0 Hz) which collapsed on irradiation of the CH-N signal, establishing
that the CH-N was H3. Similar resolution enhancement of the signal assigned to
H5 showed it to be a 1.1 Hz doublet; irradiation of the CH-O signal collapsed this
doublet establishing that the CH-O was H4. Consequently, it can be concluded that
attack by deoxyguanosine had occurred at C3 of CPPE.
The site of attachment to deoxyguanosine could be assigned as N2 on the
basis of vicinal coupling of H3 to an amino proton; the amino proton appeared at
87.11 which is consistent with NH signals of other PAH derivatives of
deoxyguanosine linked to N2. Reaction at N1, N7, 06 of guanine or the hydroxyl
groups of deoxyribose would have led to isomeric structures which lacked the
coupled NH signal. Those structures would have retained the 2-NH2 group;
however, no signal was detected which could be ascribed an NH2 group. Additional
evidence supporting the N2 assignment included the fact that the protons on N1 and
03' and 05' were still present; the guanine 1-NH signal was observed at 610.88
and the 3' and 5' hydroxy groups of deoxyribose could be observed under
conditions of slow exchange as a doublet (65.2) and triplet (65.14), respectively.
3.4 Discussion
Our results provide definitive evidence that the major adducts formed by
reaction of CPPE with deoxyguanosine in vitro are the two diastereoisomers of cis-
3-(deoxyguanosin-2-yl)-4-hydroxy-3,4-dihydroCPP, and further indicate that they
are also the major products formed when CPPE reacts with DNA. In a preliminary
publication the adducts were tentatively assigned as FAPy derivatives arising from
hydrolysis of N7 adducts (Hsu et al., 1995). The structure was based primarily on
1H NMR data that turned out to be compromised by the presence of an impurity in
the sample that made it appear that the NH2 group on C2 of the purine was still
intact. Mass spectral data were inconsistent with this assignment. In addition, the
1H NMR spectra of purified material strongly support the deoxyguanosine nucleus
still being intact. FAPy structures exist as mixtures of rotomers around in the
nitrogen-formamide and nitrogen-pyrimidine bonds leading to 1H spectra which
would be composites of the individual spectra of four rotomers for each CPP
diastereomer. The two diastereomers were well-defined single species which
showed no tendency to equilibrate to additional forms on standing.
Preferential reaction at N2 of deoxyguanosine is consistent with the reaction
preference of bay region PAH diol epoxides. The site of reaction of CPPE with
nucleophiles has generally been presumed to be C3 based upon calculations of the
relative stabilities of C3 and C4 carbocations of CPP. In addition, Gold and
coworkers have reported that nucleophilic attack by ammonia occurs exclusively at
C3 of CPPE (Sangaiah et al., 1992). However, to our knowledge no detailed NMR
or other structural studies of CPPE adducts have previously been made which prove
that C3 is in fact the preferred site of reaction.
A second radioactive fraction F1 was also observed in the enzymatic digest
of DNA that had reacted with CPPE. This fraction appeared to contain one or more
deoxyguanosine adducts, since it was observed when [3H]-deoxyguanosine was
introduced into the DNA. It seems likely that one or both of the diastereoisomers
of trans-3-(deoxyguanosin-N2-yl)-4-hydroxy-3,4-dihydroxyCPP are present in Fl.
F1 has the same chromatographic relationship to the trans-dihydrodiol as the cis
adduct has to the cis-dihydrodiol. The ESI mass spectra of the adduct(s) obtained
from the dGuo reaction, which elute(s) in the same region as Fl, exhibit the same
molecular and fragment ion as the do the spectra of the cis adducts. Although these
ions are unlikely to be unique to the N2 adduct structure, the MS data are at least
consistent with it, and support the idea that reaction of CPPE with DNA forms one
or both trans adduct isomers as well as the cis isomers.
The mechanism for preferential formation of a cis adduct deserves further
attention. It is possible that the cis adduct is arising from attack of chloride ion or
other nucleophiles on CPPE to form a trans product which then reacts with the
nucleosides to give the cis product. Chloride ion was 0.05 M in the reaction
mixtures of CPPE with both the nucleoside and calf thymus DNA. Meehan has
found evidence for a transient chlorohydrin in the formation of cis deoxyguanosine
adducts of the diol epoxide of BaP (Wolfe et al., 1994).
This study was designed to identify the major adducts that form in the
reaction of CPPE with DNA. Whether the same adducts predominate in vivo when
living organisms are exposed to CPP depends on whether CPPE is indeed the major
metabolite formed that reacts with DNA. Recent evidence indicates that it is (Beach
et al., 1993; Beach and Gupta, 1994), so the adducts formed in vivo should be those
described in this study.
3.5 Summary
Cyclopenta[cd]pyrene (CPP) is a ubiquitous environmental pollutant whose
3,4-epoxide (CPPE) is generally regarded as its ultimate carcinogenic metabolite.
The present study was undertaken to determine the structures of major DNA adducts
formed by CPPE in vitro. Comparison of these adducts with adducts formed in
vivo may be useful for elucidating the actual mechanisms of DNA damage by CPP
in living organisms. Calf thymus DNA was reacted with [3H]-CPPE and
deoxynucleoside adducts were obtained by enzymatic digestion of the adducted
DNA. These adducts were compared chromatographically with the products
obtained by reaction of CPPE with 2'-deoxyguanosine (dG), which yielded two dG
adducts that were identified by 1H-NMR and FAB-MS as diastereoisomers of cis-3-
(deoxyguanosin-N2-yl)-4-hydroxy-3,4-dihydroCPP. Other products that may have
included the isomeric trans-N2-dG adduct were formed in the reaction, but attempts
to purify them were hindered by the high proportion of trans-3,4-diol present. The
major adduct fraction in the DNA digest, accounting for over 70% of the total, was
chromatographically indistinguishable from the two cis dG-N2 adducts. A second
DNA adduct fraction was observed, which appeared also to be formed by reaction
with guanine as indicated by experiments in which DNA containing [3H]-guanine
was reacted with unlabelled CPPE. The results confirm that guanine is the major
target in DNA for reaction with CPPE and are the first spectrochemical evidence
to show that dG-N2 is the nucleophilic partner in the reaction.
Figure Legends
Figure 3.1 Structures of CPP, its 3,4-epoxide, and adducts formed by
reaction of the epoxide with the N2 of guanine.
Figure 3.2 Radiochromatogram obtained from the reversed-phase HPLC
analysis of the enzymatic digest of calf thymus DNA after reaction with [3H]-CPPE.
Indicated retention times of the cis- and trans-3,4-diols that are CPPE hydrolysis
products were determined by analysis of standards.
Figure 3.3 Radiochromatogram obtained from the reversed-phase HPLC
analysis of the enzymatic digest of [8- 3H]-guanyl calf thymus DNA after reaction
with CPPE. Indicated retention times of the cis- and trans-3,4-diols were determined
by UV detection of residual product.
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Table 1. 1H NMR Spectrum of CPPE-Deoxyguanosine Adducta
Chemical Shift (8) Multiplicity
Gua 1-NH 10.88 s
CPP H8b 8.36 dd
CPP HI 8.28 d
CPP H6b 8.27 dd
CPP H9 8.19 s
CPP H10 8.19 s
CPP H5 8.15 d
CPP H2 8.12 dd
CPP H7 8.08 dd
Gua H8 8.04 s
Gua 2-NH 7.11 d
CPP 4-OH c  6.32 d
Deoxyribose HI' 6.28 dd
CPP H3 (CH-N) 6.14 dd
CPP H4 (CH-O) d  5.84 dd
Deoxyribose 3'-OH c  5.20 d
Deoxyribose 5'-OHc  5.14 t
Deoxyribose H3 ' e 4.36 dddd
Deoxyribose H4' 3.79 ddd
Deoxyribose H5'  3.55 ddd
Deoxyribose H5'' f  3.49 ddd
Deoxyribose H2' 2.70 ddd
Deoxyribose H2" 2.29 ddd
J1,2=7.8 Hz, J2 ,3=1.0, J3,4=6.6, J3,NH=7.8, J4,OH=6.3, J4,5=1.1
J6,7= 7 .7C , J6,=0.8, J7,8= 7.3 C, J9,I0=n.d., Jl',2=7.7, J- 2',2 =6.3
J2',2"=13.2, J2',3,=6.0, J2",3,=3.1, J3',4,=3.0, J3',oH= 5 .2 , J4',5.=5.0
J4,5",,=6.4, J5,,5,,= 11.6, Js,,OrtH-5.1, J5,,,OH=--5.1
a Spectra were recorded of solutions in DMSO-d6 on a Bruker AM 400 spectrometer at 270C.
The values shown are for the adduct that eluted last from the reverse phase HPLC column.
In no case did chemical shifts of the two diastereomers differ by more than 0.05 ppm.
b Assignments may be reversed.
c Not observed under conditions of fast proton exchange.
d Collapsed to a doublet under conditions of fast proton exchange.
e Collapsed to a doublet of doublets of doublets under conditions of fast proton exchange.
f Collapsed to a doublet of doublets under conditions of fast proton exchange.
4. DNA adduct formation by metabolites of cyclopenta[cd]pyrene in vitro
4.1 Introduction
CPPE has been proposed as the ultimate carcinogenic form of CPP and it has
been shown that the major DNA adducts formed in vivo co-chromatograph on TLC
with dG adducts formed by the reactions of CPPE in vitro. These studies have not
provided definitive evidence that dG-CPP arises solely through reaction with CPPE
in vivo, nor have they precluded the possibility that other bases are alkylated by
CPPE or other reactive intermediates produced from CPP. Two important
metabolites of CPPE, CPP-3,4-diol and 4-OH-DCPP, have been shown to react with
DNA and to be mutagenic when activated by sulfotransferase. The first of these
would be expected to produce the same adduct as CPPE. 4-OH-DCPP would yield
a unique adduct but there is no certainty that it would be separated from dG-CPP
under the chromatographic conditions used to detect in vivo adducts. The present
study was thus undertaken to characterize the binding of these two secondary
metabolites with DNA and to determine if bases other than guanine are alkylated
by CPPE.
4.2 Materials and methods
Chemicals and Enzymes
CPP and [G-3H]CPP were products of the Midwest Research Institute
(Kansas City, MO) and the Chemsyn Science Laboratory (Lenexa, KS), respectively,
and were obtained from the National Cancer Institute Chemical Carcinogen
Repositories. CPPE and [3H]CPPE were prepared from CPP with dimethyldioxirane
in dichloromethane (Kwon et al., 1992). CPP-3,4-diol and [3H]CPP-3,4-diol were
made from CPPE by acid hydrolysis and purified to separate the trans- and cis-
isomers. [3H]4-OH-DCPP was obtained by [3H]NaBH 4 reduction (New England
Nuclear Products, Boston, MA) of 4-oxo-DCPP, which was prepared by
rearrangement of CPPE in benzene. The sulfuric acid ester of 4-OH-DCPP was
prepared as the sodium salt by N,N'-dicyclohexylcarbodiimide-mediated coupling
of sulfuric acid to 4-OH-DCPP in dimethylformamide (DMF) (Surh et al., 1993).
Radiolabeled calf thymus DNA containing [8- 3H]guanine, [1',2',2,8- 3H]adenine, or
[1 ',2',5- 3H]cytosine, was prepared using the Nick Translation System of Promega
(Madison, WI) to incorporate selected [3H]dNTPs, which were obtained as the
ammonium salts from Amersham Life Science (Arlington Heights, IL). Calf thymus
DNA was sonicated and extracted with phenol prior to use. The amount of labeled
dNTPs incorporated into the DNA was determined by the DE81 filter-binding assay
(Sambrook et al., 1989). The typical percentage of incorporation ranged from 25%
to 45%. The enzymes for digestion of the modified calf thymus DNA by CPP
metabolites were DNase I (from bovine pancreas), phosphodiesterase II (from calf
spleen), snake venom phosphodiesterase (from Crotalus durissus), and alkaline
phosphatase (from calf intestine). All these enzymes were products of Boehringer
Mannheim Biochemicals (Indianapolis, IN), except DNase I, which was purchased
from Sigma Chemical Co. (St. Louis, MO). The digestion of modified DNA has
been described in previous section. Rat liver cytosol was prepared from
postmitochondrial supernant fractions supplied by Molecular Toxicology, Inc.
(Annapolis, MD). All other chemicals and solvents used were reagent grade.
Preparation and Isolation of Modified DNA
Calf thymus DNA was treated with CPPE (20 nmol/mg DNA) in a 50 mM
Tris-HCl buffer (pH 7.4) at 370C for 2 hr. CPP-3,4-diol and 4-OH-DCPP were
incubated with calf thymus DNA (20 nmol/mg DNA) in the presence of rat liver
cytosol and 3'-phosphoadenosine-5'-phophosulfate (PAPS) at 370 C for 2 hr. Each
reaction mixture was extracted twice with a half volume of water-saturated ethyl
acetate to remove unbound CPP derivatives, and DNA was isolated by ethanol
precipitation. Phenol/chloroform extraction was performed to remove cytosolic
proteins in the sulfotransferase-mediated activation reactions (Surh et al., 1993). To
every 50 ug of nick translated DNA, 13.3 nmol of various CPP metabolites were
added.
Synthesis of trans-3-(deoxyadenosin-N6-yl)-4-hydroxy-3,4-dihydroCPP
CPPE was allowed to react with liquid NH3 and one equivalent of H20 as
described (Sangaiah et al., 1992). This procedure has been reported to yield trans-
4-amino-3-hydroxy-3,4-dihydroCPP, but when the product was analyzed by GC-MS
it was found to be a mixture of two isomers in nearly equal amounts. The isomers
were inseparable by HPLC. GC-MS was conducted with a Hewlett Packard 5971A
equipped with a standard El source and 15 mm x 0.2 mm HP1 fused silica capillary
column. bis-Trimethylsilyl derivatives were prepared by treating with a mixture of
N, O-bis-(trimethylsilyl)trifluoroacetamide (BSTFA), pyridine, and acetonitrile (5:2:2,
v:v) for 1.5 hr at 600. Spectra obtained from each isomer were nearly identical: m/z
403 (M+), 388 (M+-CH 3), 330 (M+-TMS), 313 (M+-TMSOH), 240 (M+-TMS-
TMSOH). Pentafluoropropionamide derivatives were prepared by treatment with
pentafluoropropionic anhydride, saturated trimethylamine in hexane, and
dichloromethane (1:10:50, v:v) for 1.5 hr at room temperature. This derivative of
each isomer also gave virtually identical spectra: m/z 387 (M+-H 20), 240 (M+-H 2O-
COC 2F5).
The reaction of CPPE with NH3 can yield a maximum of 4 isomers,
depending on the position of nucleophilic attack as well as the stereochemistry of
ring opening. Under the reaction conditions used there is little possibility of cis
attack on the epoxide. Thus the isomers must be positional, one being trans-3-
amino-4-hydroxy-3,4-dihydroCPP and the other trans-4-amino-3-hydroxy-3,4-
dihydroCPP. Since we were unable to separate the two by HPLC, the mixture was
used for the remainder of the synthesis.
trans-3-(Deoxyadenosin-N6-yl)-4-hydroxy-3,4-dihydroCPP and trans-4-
(deoxyadenosin-N6-yl)-3-hydroxy-3,4-dihydroCPP were obtained by the reaction of
trans-CPPAA with 6-chloropurine 2'-deoxyriboside in refluxing ethanol for 48 hr
as described for the syntheses of acenaphthene and aceanthrene oxide adducts
(Bartczak et al., 1989). HPLC analysis of the products revealed only one with the
expected pyrene-like UV spectrum. This product gave the correct mass by
ionspray-MS: m/z 494 (MH+) and 516 (MNa+). Spectra were acquired with a PE
SCIEX Ionspray-API 1 LC/MS system (Toronto, Canada). The product is presumed
to be an unresolvable mixture of positional isomers since the amino alcohol was a
mixture.
Chromatography
The DNA digests were analyzed by reverse phase HPLC (Hewlett Packard
HP 1090, equipped with a diode array detector, Palo Alto, CA) with a fluorescence
detector (Spectroflow 980, ABI analytical Inc., CA). Excitation was at 341nm and
a 370nm cut off filter was used on the emission. Columns (4.6 mm x 250 mm or
7.8 mm x 250 mm) were Nucleosil Cl 8 from Alltech Assoc. Inc. (Deerfield, IL)
and the following gradient for separating CPP metabolites and DNA adducts at the
flow rate of 1 ml/min or 3 ml/min, depending on column size, was used: an
isocratic phase of 50% methanol in water for 5 min, linear gradient to 80%
methanol at 55 min, and to 100% at 60 min. To isolate CPPAA from the reaction
mixture, an acetonitrile/water gradient containing 0.05% trifluoroacetic acid (TFA)
was applied. The solvent program was a 3-min isocratic phase of water followed
by a linear gradient to 50% acetonitrile in water at 25 min, and to 100% at 40 min.
For radioactive samples, the eluting fractions were collected every minute, and the
radioactivity of each fraction was measured upon addition of liquiscint (National
Diagnostics, Atlanta, GA) in a Beckman LS6000 counter (Fullerton, CA).
4.3 Results and Discussion
Characterization of DNA adducts formed by serveral different CPP
metabolites was undertaken in this study. In agreement with an earlier report
(Beach and Gupta, 1994), our study shows that CPPE preferentially reacts with
guanine than with other bases. We also demonstrate here that two other major CPP
metabolites, 4-OH-DCPP and trans-CPP-3,4-diol, predominantly yield
deoxyguanosinyl adducts.
The covalent binding of [3H]CPPE to DNA in vitro resulted in a level of
DNA base modification equal to one hydrocarbon adduct per 15,000 nucleotides.
The HPLC radiochromatogram shown in Figure 4.1 reveals that two major products
are formed of the enzyme digest of this adducted DNA. The components eluting
before 10 min on the profile were not investigated further in this study since they
were too polar to be deoxynucleoside adducts. Trace amounts of trans- and cis-CPP-
3,4-diol were observed.
In order to establish the identity of the base(s) that react with CPPE, specific
radiolabelled deoxyribonucleotides were introduced into the DNA by nick
translation prior to its reaction with nonradioactive CPPE. Previous studies show
that thymine is a minor site, at best, of modification of DNA by PAHs, so it was
not investigated (Hemminki, 1983; Dipple, 1995). The nick translated [3H]DNA was
treated with CPPE and digested for HPLC analysis. The results from CPPE-treated
[3H-dG]DNA (Figure 4.2) indicated that the two major fractions produced by
[3H]CPPE-treated DNA (Fl and F2 in Figure 4.1) are CPP-dG adducts. Further
incubations of CPPE with the nick-translated [3H-dA]DNA (Figure 4.3) and [3H-
dC]DNA (Figure 4.4) showed that CPPE also bound covalently to A and C in DNA,
but on the order of 10 and 100 times lower, respectively, than it bound to G. This
comparative binding ratio of individual bases in DNA was determined by dividing
the total radioactivity of the adducted peaks resolved in HPLC by the total
radioactivity injected. Results from experiments with [3H-dA]DNA and [3H-
dC]DNA provide additional evidence that the two major CPPE-DNA adducts are
deoxyguanosine-specific since the products formed migrated differently from F1 and
F2 on HPLC.
The later eluting adduct fraction (F2 in Figure 4.1) of the reaction of
[3H]CPPE and DNA co-migrated with authentic diastereomeric cis-3-
(deoxyguanosin-N2-yl)-4-hydroxy-3,4-dihydroCPP, obtained from the reaction of
CPPE and dG. The earlier eluting adduct fraction (FI in Figure 4.1) was presumed
to be the corresponding trans- isomer for the reasons discussed (also see below), but
this assumption remains unproven.
The two fractions obtained in the reaction of [3H-dA]DNA with CPPE
(Figure 4.3) can be identified, by a similar line of reasoning, as cis- and trans-
isomers of 3-(deoxyadenosin-N6-yl)-4-hydroxy-3,4-dihydroCPP. A1, the earlier
eluting peak, co-migrated with the product obtained by reacting trans-CPPAA with
6-chloropurine-2'-deoxyriboside. This reaction product was almost certainly
composed of a mixture of 3,4- and 4,3- isomers since the amino alcohol from which
it was made was an inseparable mixture, but the trans geometry and N6 position of
substitution in the purine ring, which are structural elements that would be expected
to have a pronounced influence on HPLC retention time, are unambiguous in this
synthetic strategy. Thus, the identification of Al is reasonably certain. A2 is
presumed to be the cis isomer of the same adduct, since it elutes later (see below)
and since exclusive formation of the trans isomer is unlikely in view of the
predominance of the cis-dG adduct.
Only one fraction (Cl in Figure 4.4) was obtained from the reaction of CPPE
and [3H-dC]DNA. No evidence was obtained for its structure, but it may be
speculated that the stereochemistry of CPPE ring opening in this adduct is cis
because cis adducts were the predominant adducts observed with guanine and
adenine in DNA. In addition, the retention time of this adducted fraction is
consistent with cis stereochemistry (see below).
Adduct identification in this study was based on reactivity considerations and
on chromatographic comparisons. Highly reactive PAH epoxides and diol epoxides
react predominantly by the SN1 mechanism at neutral pH, typically leading to a
mixture of cis and trans products. For example, F2 was shown to contain cis
adducts by co-chromatography with authentic material. Fl was, therefore,
considered to be the corresponding trans isomer since it is reasonable to assume that
both cis and trans opening of the epoxide ring are likely occur. Also, in several
other cases it has been established that trans disubstitued dihydroPAHs elute earlier
than their corresponding cis forms on reverse phase HPLC. Examples here include
CPP-3,4-diols (Sahali et al., 1992), 3-methoxy-4-hydroxy-3,4-dihydroCPP
derivatives (Hsu et al., 1996c), and others (Delclos et al., 1988; Bigger et al., 1978;
Roy et al., 1991). Accordingly, the earlier retention value of F1 also supported its
trans assignment. Based on these considerations, A2 was then presumed to be the
cis form since Al was shown to be the trans deoxyadenosinyl adduct. The findings
reported here are consistent with the idea that adducted dG or G always elutes
earlier than adducted dA or A on reverse phase HPLC when DNA is modified by
PAHs (Canella et al., 1992; Babson et al., 1986; Cheh A.M. et al., 1993; Li et al.,
1993; Misra et al., 1992; Jennette et al., 1977; Straub et al., 1977; Chadha et al.,
1989; Melikian et al., 1988; Lurie et al., 1988; Phillips et al., 1981; Mlcoch et al.,
1993; Alexandrov et al., 1988; Rojas and Alexandrov, 1986; Cheng et al., 1989;
Nair et al., 1989; Marletta and Szuba, 1988; Carmella and Hecht, 1987; Surh et al.,
1989; Surh et al., 1991a; Surh et al., 1990). To our knowledge, this generalization
has never been stated previously, but it appears true for a number of cases. Cl was
assigned cis- geometry for the following two reasons. Substituted dC or C should
elute only slightly earlier than substituted dG or G on reverse phase HPLC (Surh
et al., 1989; Straub et al., 1977; Jennette et al., 1977) and other CPPE-derived DNA
adducts in this study were found to be predominately cis adducts.
Sulfotransferase activation was used to generate DNA adducts from CPP-3,4-
diols and 4-OH-DCPP. Liver cytosol from male rats was used in this study, since
it has the highest sulfotransferase activity for 4-OH-DCPP (the only CPP derivative
tested) when compared to that of male mice, female mice and rats (Surh et al.,
1993). Not surprisingly, no adduct was detected by HPLC-fluorescence or by
radiochromatography in the sulfotransferase-mediated reaction of cis-CPP-3,4-diol
modified DNA: this isomer has previously been shown to give only very low levels
of sulfotransferase-dependent DNA binding (Surh et al., 1993). In contrast,
sulfotransferase-dependent binding of [3H]trans-CPP-3,4-diol gave one hydrocarbon
adduct per 50,000 nucleotides. In this experiment, two radioactive fractions with
the retention times of F1 and F2 were observed (DIOL1 and DIOL2 in Figure 4.5),
suggesting that trans- and cis-3-(deoxyguanosin-N2-yl)-4-hydroxy-3,4-dihydroCPP
were the products formed. As a partial test of this inference, trans-3,4-diol was
reacted with nick-translated [3H-dG]DNA. The same two radioactive fractions were
obtained (DIOL1 and DIOL2 in Figure 4.6), confirming that reaction takes place
with guanine. Although the adducts obtained in the sulfotransferase-mediated
binding of CPP-3,4-diol co-chromatograph with known adducts, their stereochemical
characterization remains incomplete because it cannot be determined whether the 3-
or 4-hydroxyl group of CPP-3,4-diol is sulfated by the enzyme prior to attack DNA.
Thus, the minor dG adduct (DIOLI) might be one or both of trans-3-
(deoxyguanosin-N2-yl)-4-hydroxy-3,4-dihydroCPP andtrans-4-(deoxyguanosin-N2-
yl)-3-hydroxy-3,4-dihydroCPP, and the major dG adduct might be a mixture of the
corresponding cis isomers.
Sulfotransferase-activated trans CPP-3,4-diol and CPPE apparently produced
similar ratios of stereoisomers in their reaction with guanine, suggesting that the
same reactant is involved. The reactant could be the fully formed C3-carbocation
produced by epoxide ring-opening or by heterolysis of the C3-sulfate bond. If the
nucleophilic partner in these reactions were involved in the transition state, different
stereochemical outcomes would be expected because the bond being broken in
CPPE is cis to the final C4-hydroxyl group, while the bond being broken in the
sulfate ester is trans. This inference that the fully formed C3-carbocation is the
ultimate reactant in both cases is not unreasonable, but we note that another
interpretation is possible: the common reactant could be CPPE itself, formed by the
action of sulfotransferase on the trans diol. CPPE has been synthesized by the
action of the tosyl chloride and base on the trans diol (Sahali et al., 1990).
Depending on the conditions within the active site of the sulfotransferase, it is
conceivable that the same intramolecular displacement (of a sulfate rather than a
sulfonate group) could take place. This mechanism would explain the lack of
reactivity of cis-CPP-3,4-diol. Of course, it may be that the cis diol is not a good
substrate for the enzyme. The common stereochemical course of the reactions
preludes determining which reactant predominates in vivo without additional
information.
The covalent binding of 4-OH-DCPP to DNA in the presence of rat cytosol
and PAPS resulted in a level of DNA modification equal to one hydrocarbon adduct
per 2,500 nucleotides. Figure 4.7 shows the HPLC-radioactivity profile of the
products obtained from the reaction of [3H]4-OH-DCPP and DNA in the
sulfotransferase-mediated incubation. With fluorescence detection, two closely
eluting peaks were apparent in the region of OH2. These correspond to the
products obtained from reaction of synthetic 4-NaO 3S-O-DCPP or sulfotransferase-
activated 4-OH-DCPP with deoxyguanosine. The two adducts in fraction OH2 are
thus presumed to be a diastereomeric pair of adducts formed by nucleophilic
substitution of the sulfate group by guanine. The minor component (OH1 in Figure
4.7), not always observed in the radiochromatogram, eluted from the column at
approximately 32 min. This more polar fraction was formed in the absence of DNA
or dG and so is assumed not to be an adduct. Two products were obtained from
attempted reaction of 4-NaO3 S-O-DCPP with deoxyadenosine and they eluted
around 45 min on our HPLC system.
The present study is the first to report DNA adduct formation by secondary
metabolites of CPP. It also concludes that the same major DNA adducts are formed
by CPPE and sulfotransferase-activated trans CPP-3,4-diol. These findings suggest
that in addition to CPPE, CPP-3,4-diol may also be involved in CPP-DNA adduct
formation in vivo (Nesnow et al., 1994; Beach and Gupta, 1994). Adducts derived
from 4-OH-DCPP were obtained and distinguished on our HPLC system from
CPPE-derived adducts. Guanine residues were found to be the primary targets of
DNA modification by the various CPP metabolites that we tested. The availability
of the adducts resulting from this work and use of our chromatographic conditions
should aid the identification of electrophilic species of CPP in vivo.
bases in DNA directly to produce the benzylic DNA adducts efficiently (Okuda et
al., 1989; Surh et al., 1987; Surh et al., 1991a; Surh et al., 1989; Surh et al., 1990;
Watabe et al., 1985; Watabe et al., 1987). For example, some sulfooxymethyl
PAHs yielded higher amounts of DNA adducts than did the corresponding parent
hydroxymethyl PAHs when administrated intraperitoneally to infant rats (Surh et al.,
1987; Surh et al., 1991a; Surh et al., 1989; Surh et al., 1990). The carcinogenicity
of 6-sulfooxymethylBaP was also found to be higher than those of 6-
hydroxymethylBaP and BaP (Surh et al., 1991b). As tumor initiators, 9-
sulfooxymethyl- 10-methylanthracene and 1I-sulfooxymethylpyrene were more active
than the parent agents (Surh et al., 1990).
2.4.1.2 Cyclopenta-fused aromatic hydrocarbons
4-OH-DCPP and CPP-3,4-diols contain secondary benzylic hydroxyl groups
in the cyclopenta ring. Significant covalent DNA binding of these CPP metabolites
were observed in the presence of rodent cytosol and PAPS, and the binding could
be inhibited by both DCNP and DHEA (Surh et al., 1993). These results indicated
that either the phenol sulfotransferase or hydroxy-steroid sulfotransferase was
capable to activate these compounds.
The bay-region diol epoxides are generally recognized as the ultimate
carcinogenic metabolites of a large group of PAHs. However, adducts formed from
enzymatic one-electron oxidations of BaP and DMBA have also been characterized
and their carcinogenesis is of great interest (RamaKrishna et al., 1992b; Devanesan
et al., 1992; RamaKrishna et al., 1992a). For methyl-substituted PAHs,
hydroxylation of meso-methyl groups with subsequent formation of reactive benzylic
esters bearing a good leaving group such as acetate, phosphate, or sulfate has been
proposed as a possible or an alternative mechanism of activation, carcinogenesis,
and DNA binding of these hydrocarbons (Flesher and Sydnor, 1971; Flesher and
Sydnor, 1973).
Methyl-substituted PAHs that have been studied using sulfotransferase
activation include 7-hydroxy-12-methylbenz[a]anthracene (Watabe et al., 1982), a
major metabolite of 7,12-dimethylbenz[a]anthracene, 7,12-
dihydromethylbenz[a]anthracene (Watabe et al., 1987), 7-
hydroxymethylbenz[a]anthracene (Watabe et al., 1986), 5-hydroxymethylchrysene
(Okuda et al., 1989), 6-hydroxymethylBaP (Surh et al., 1989), 9-hydroxymethyl-10-
methylanthracene (Surh et al., 1990), and 1-hydroxymethylpyrene (Surh et al.,
1991a; Surh et al., 1990). All of these PAHs exhibited mutagenicity using Ames
test and formed benzylic adducts with dG and dA in calf thymus DNA in the
presence of rodent liver cytosol and PAPS. DHEA substantially inhibited their
mutagenicity and DNA binding but PCP and DCNP did not. This information
together with the result that purified hydroxysteroid sulfotransferase showed high
catalytic activity for hydroxymethyl PAHs (Ogura et al., 1990) suggested hydroxy-
steroid sulfotransferase may be responsible for the sulfotransferase-mediated
activation of these compounds.
The chemically synthesized sulfuric acid esters of these hydroxymethyl PAHs
are extremely potent mutagens and can react with guanine, adenine, and cytosine
4.4 Summary
Cyclopenta[cd]pyrene (CPP) is a common carcinogenic environmental
contaminant. Although the 3,4-epoxide (CPPE) is recognized as a potent mutagen,
other metabolites arising from CPPE also exhibit the ability to react with and cause
mutations in DNA. In this study, we compared these other metabolites to CPPE
with respect to the adducts formed in their reaction with DNA. Calf thymus DNA
was reacted in vitro with CPPE or with its metabolites, 3,4-dihydroCPP-3,4-diol
(CPP-3,4-diol) and 4-hydroxy-3,4-dihydroCPP (4-OH-DCPP), activated with
sulfotransferase. The adducts formed were analyzed by HPLC with fluorescence
detection following enzymatic digestion of DNA to deoxynucleosides.
Radiolabeling of specific DNA bases prior to reaction demonstrated that the two
major CPPE-derived adducts were formed by guanine, while minor adducts were
formed by adenine and cytosine. The major dG adduct formed in DNA was
identified as cis-3-(deoxyguanosin-N2-yl)-4-hydroxy-3,4-dihydroCPP and the minor
dG adduct seems likely to be its trans isomer. Adenosine adducts were presumably
formed by aralkylation of the N6 position since they co-chromatographed with the
regio-specifically synthesized standard, which was prepared by reaction of trans-3,4-
dihydroCPP amino alcohol with 6-chloropurine 2'-deoxyriboside. Sulfotransferase
activation of trans-CPP-3,4-diol yielded two adducts that were identical to the
products resulting from the reaction of CPPE with DNA, while cis-CPP-3,4-diol
gave very low covalent binding. Two adducts formed by sulfotransferase activation
of 4-OH-DCPP were identical to the diastereomeric products generated from the
reaction of synthetic 4-NaO3S-O-DCPP with dG. These results indicate that
guanine is predominantly the site of CPP adduct formation in DNA, regardless of
the identity of the reactive metabolite, and that the 4-hydroxy-3-dG adducts can
arise by reaction of DNA with either CPPE or sulfotransferase-activated trans-CPP-
3,4-diol.
Figure Legends
Figure 4.1 Radiochromatogram obtained from the reversed-phase HPLC
analysis of the enzymatic digest of calf thymus DNA after reaction with [3H]CPPE.
Indicated retention times of the cis- and trans-3,4-diols that are CPPE hydrolysis
products were determined by analysis of standards. The fraction eluting before 10
min on the profile was not investigated further since they were too polar to be
deoxynuceloside adducts. Fl was considered to be trans-3-dG-4-OH-DCPP and F2
was shown to contain cis-3-dG-4-OH-DCPP.
Figure 4.2 Radiochromatogram obtained from the reversed-phase HPLC
analysis of the enzymatic digest of [8- H]guanyl calf thymus DNA after reaction
with CPPE. Indicated retention times of cis- and trans-3,4-diols were determined
by UV detection of residual product. GI was considered to be trans-3-dG-4-OH-
DCPP and G2 was shown to contain cis-3-dG-4-OH-DCPP.
Figure 4.3 Radiochromatogram obtained from the reversed-phase HPLC
analysis of the enzymatic digest of [1',2',2,8- 3H]adenyl calf thymus DNA after
reaction with CPPE. Indicated retention times of cis- and trans-3,4-diols were
determined by UV detection of residual product. Al was shown to contain trans-3-
dA-4-OH-DCPP and A2 was considered to be cis-3-dA-4-OH-DCPP.
Figure 4.4 Radiochromatogram obtained from the reversed-phase HPLC
analysis of the enzymatic digest of [1',2',5- 3 H]cytosinyl calf thymus DNA after
reaction with CPPE. Indicated retention times of cis- and trans-3,4-diols were
determined by UV detection of residual product. C1 was thought to be cis-3-dC-4-
OH-DCPP.
Figure 4.5 Radiochromatogram obtained from the reversed-phase HPLC
analysis of the enzymatic digest of calf thymus DNA after reaction with
sulfotransferase-activated [3H]trans-CPP-3,4-diol. Indicated retention times of the
cis- and trans-3,4-diols were determined by analysis of standards. The fraction
eluting before 10 min on the profile was not investigated further since they were too
polar to be deoxynuceloside adducts. DIOL1 was considered to be the mixture of
trans-3-dG-4-OH-DCPP and trans-3-OH-4-dG-DCPP and DIOL2 was assigned to
be the mixture of cis-3-dG-4-OH-DCPP and cis-3-OH-4-dG-DCPP by comparison
to the cis-3-dG-4-OH-DCPP standards.
Figure 4.6 Radiochromatogram obtained from the reversed-phase HPLC
analysis of the enzymatic digest of [8- 3H]guanyl calf thymus DNA after reaction
with sulfotransferase-activated trans-CPP-3,4-diol. Indicated retention times of cis-
and trans-3,4-diols were determined by UV detection of residual product. DIOL1
was considered to be the mixture of trans-3-dG-4-OH-DCPP and trans-3-OH-4-dG-
DCPP and DIOL2 was assigned to be the mixture of cis-3-dG-4-OH-DCPP and cis-
3-OH-4-dG-DCPP by comparison to the cis-3-dG-4-OH-DCPP standards.
Figure 4.7 Radiochromatogram obtained from the reversed-phase HPLC
analysis of the enzymatic digest of calf thymus DNA after reaction with
sulfotransferase-activated [3H]4-OH-DCPP. Indicated retention time of the 4-OH-
DCPP were determined by analysis of standard. OH1 was not formed in the
absence of DNA or dG and so is assumed not to be an adduct. OH2 was proved
to be 4-dG-DCPP by comparing it to the reaction products of 4-NaOSO 3-DCPP and
individual nucleosides (dA and dG).
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5. Characterization of cyclopenta[cd]pyrene-DNA adducts formed in vivo
5.1 Introduction
Using 32P-postlabelling analysis, Nesnow et al. found that DNA adducts
from CPP-treated A/J mouse lung tumor were CPPE-derived guanines (Nesnow et
al., 1994). Beach and Gupta reported that in CPP-treated Sprague-Dawley rat lung,
B6C3F1 mouse lung, and NIH Swiss mouse skin DNA, adducts were also formed
by CPPE (Beach and Gupta, 1994). In previous section, trans-CPP-3,4-diol and 4-
OH-DCPP were shown to reacted with DNA when activated by sulfotransferase and
the same major CPP-dG adducts were yielded by either CPPE or trans-CPP-3,4-diol.
Although adducts derived from 4-OH-DCPP were separated from CPPE-adducted
dG adducts under the chromatographic conditions described here, there is no
certainty that they would be distinguished in the in vivo studies (Nesnow et al.,
1994; Beach and Gupta, 1994). In addition, the possibility of forming adducts by
the diolepoxides of CPP deserves further investigation.
This present study was undertaken to identify DNA adducts formed in a
mouse model. The identification of these adducts was conducted by comparing
them to CPP metabolites and adduct standards using an HPLC-LIF system combined
with a cryogenic fluorescence spectroscopy. Accordingly, adduct-forming
metabolites of CPP were deduced. To our knowledge this is the first report to
investigate the formation of PAH-DNA adducts in vivo by this kind of system
without adduct hydrolysis.
5.2 Materials and Methods
Materials
Male CD-1 mice were obtained from Charles River Associates (Wilmington,
MA) a week before treatment. CPP and [G- 3H]CPP were products of the Midwest
Research Institute (Kansas City, MO) and the Chemsyn Science Laboratory (Lenexa,
KS), respectively, and were obtained from the National Cancer Institute Chemical
Repository. CPPE was prepared from CPP with dimethyldioxirane in
dichloromethane (Kwon et al., 1992). CPP-3,4-diols were made from CPPE by acid
hydrolysis and purified to separate the trans and cis isomers. 4-OH-DCPP was
obtained by NaBH4 reduction of 4-oxo-DCPP, which was prepared by
rearrangement of CPPE in benzene. The enzymes for digestion of DNA were
DNase I (from Bovine pancreas), snake venom phosphodiesterase (from Crotalus
durissus), and acid phosphatase (from Potato). All these enzymes were obtained
from Boehringer Mannheim Biochemicals (Indianapolis, IN), except DNase I which
was purchased from Sigma Chemical Co. (St. Louis, MO). Rat liver cytosol was
prepared from postmitochondrial supernatant fractions supplied from Molecular
Toxicology, Inc. (Annapolis, MD). QIAGEN Genomic-tip 500/G were from
QIAGEN Inc. (Chatsworth, CA). All other chemicals and solvents used were of
reagent grade.
Adduct Preparation
In vivo adducts. Male CD-1 mice weighing approximately 25-30 g were housed
in suspended polycarbonate cages containing corncob bedding prior to CPP
treatment. Animals were given one dose of [3H]CPP (7 mg/kg body weight,
specific activity: 588 dpm/pmol) in 100 ul corn oil intraperitoneally. Three days
after the administration, animals were sacrificed and livers and lungs were removed.
The tissues were stored at -70 'C for subsequent DNA isolation. Isolation of DNA
from the livers and lungs of CPP-treated mice that has been described elsewhere
(Gorelick et al., 1989). Briefly, the tissues were thoroughly homogenized and
membranes disrupted by the addition of detergent. After extensive shearing, the
samples were digested with proteinase K and RNase A followed by organic
extraction. Finally, DNA was precipitated using ethanol and then subjected to
enzymatic digestion to deoxynucleoside adducts (Surh et al., 1989) prior to HPLC
analysis.
In vitro adducts. Calf thymus DNA was treated with CPPE (20 nmol/mg DNA)
in a 50 mM Tris-HCl buffer (pH 7.4) at 37 'C for 2 hr. CPP-3,4-diol and 4-OH-
DCPP were incubated with calf thymus DNA (20 nmol/mg DNA) in the presence
of rat liver cytosol and 3'-phosphoadenosine-5'-phophsulfate (PAPS) at 37 OC for
2 hr (Surh et al., 1993). Each reaction mixture was extracted twice with a half
volume of water-saturated ethyl acetate to remove unbound CPP derivatives. Then,
DNA was isolated by ethanol precipitation followed by enzymatic digestion to
dexoynucleoside adducts (Surh et al., 1989) prior to HPLC analysis.
Phenol/chloroform extraction was used to remove cytosolic proteins in the
sulfotransferase-mediated activation reactions (Surh et al., 1993).
Chromatography and Detection System
Separations were carried out by HPLC (Hewlett Packard HP 1090, Palo Alto,
CA) with a Nucleosil C18 column (4.6 mm x 250 mm, Alltech Assoc. Inc.,
Deerfield, IL) at a flow rate of 1 ml/min. The elution program used was: an
isocratic phase of 50% methanol in water for 5 min, followed by a linear gradient
to 80% methanol at 55 min, and then to 100% at 60 min. To resolve in vivo DNA
digests, HPLC combined with a Laser Induced Fluorescence (LIF) detector was
utilized. This involved irradiating the HPLC eluent in a fused silica capillary (100
um diameter) with a 30 mW CW Helium/Cadmium laser at 325 nm. The
fluorescence emission was then focused with a 40X microscope objective on to the
entrance slit of a 0.22 m Spex Monochrometer. Two photomultiplier tubes (PMT)
set up in a coincidence circuit were used to measure the fluorescence intensity. The
pyrene fluorescence intensity was determined as the intensity at 400 nm (signal)
minus the intensity at 450 nm (reference). This was then amplified using a Lock-in
amplifier (SciTec Instruments, UK) and was monitored on an IBM compatible PC
with a data acquisition board and appropriate software.
Cryogenic LIF spectroscopy
Cryogenic LIF and fluorescence line-narrowed emission spectra were
recorded with a system that has been described elsewhere with minor modifications
(Day et al., 1992). The main modification to the system was the replacement of the
diode-array detector with a cooled intensified CCD-array detector (Princeton
Instruments, Trenton NJ). Briefly, laser light was generated with a Nd-YAG laser
whose second harmonic at 532 nm pumped a dye laser. The output of the dye laser
was double by using a KDP crystal to generate laser wavelengths in the range of
300-400 nm. Typical pulse energies were in the range of 100 uJ to 1 mJ/pulse at
10 Hz and the pulse width was 5 ns. Fluorescence from the sample was collected
by a 5 cm focal length lens and focused in a 0.32 m monochrometer using a 15 cm
focal length lens. The fluorescence was detected with an intensified CCD-array
detector on an IBM compatible PC. Excitation into the origin of the first excited
state, S1, results a line-narrowed spectrum and is known as fluorescence line
narrowing (FLN). As one goes higher in the S, state or into the S2 state, the line
narrowing effects are reduced and spectra become broad due to the increased
vibrational level density. In our experiments, excitation of pyrene-based compounds
at 346 nm (S2 excitation) resulted in an intense fluorescence peak centered at 378
nm. S, excitation was achieved by tuning the laser to 355 nm and resulted in a
sharp double peak around 376 nim. To avoid amorphous crystal formation at
cryogenic temperatures the DNA digests were dissolved in a glass matrix of 5 parts
glycerol, 4 parts sample dissolved in water and 1 part ethanol. The sample (max.
30 ul) was then placed in a quartz capillary and sonicated for 15 minutes to remove
dissolved gasses. The samples were then rapidly cooled in the cryostat to 40 K with
liquid helium. Collection of the fluorescence spectra was gated by 90 ns after the
laser pulse to reduce laser scattering. The final fluorescence spectra were obtained
by the cumulative addition of spectra over 20 minutes.
5.3 Results
CD-1 mice were used in this study because their susceptibility to CPP
carcinogenesis (Wood et al., 1980; Cavalieri et al., 1981a). They were dosed with
7 mg CPP/kg in our experiments. This dose is slightly lower than those used in
previous in vivo CPP-DNA adduct studies (10-50 mg CPP/kg) (Beach et al., 1991;
Beach and Gupta, 1994; Nesnow et al., 1994). Our results indicated that CPP
adduct levels in lung DNA were 1.5 times higher than in liver DNA (4.6 pmol/mg
lung DNA vs. 3.0 pmol/mg liver DNA). Similar tissue preference was also
observed in Sprague-Dawley rats 5 days after treatment with a single dose of 10 mg
CPP/kg (2.6 pmol/mg lung DNA vs. 1.1 pmol/mg liver DNA) (Beach et al., 1991).
In contrast, the level of DNA binding in liver tissue was at least 10 times greater
than in lung tissues of CPP-treated Balb/c mice over a 15-day period (3 CPP mg/kg,
max. 0.5 pmol/mg lung DNA vs. max. 8.3 pmol/mg liver DNA) (Kwon, 1992).
The HPLC radiochromatogram of digested tissue DNA has an elevated
background in the region in which our synthesized in vitro CPPE-DNA adducts
elute (not shown here). However no distinct fraction could be obtained from the
radiochromatogram due to the low in vivo CPP binding levels. This indicated that
no CPP diolepoxide-derived DNA adducts were formed in vivo. If DNA adducts
were formed by CPP diolepoxides, it would be expected that these adducts would
elute earlier in our reversed-phase HPLC system due to their greater hydrophilicity.
However, even the injection of as much as 1 mg of digested liver DNA failed to
show any radioactivity in the regions where more polar CPP diolepoxide-adducted
nucleosides would be expected to elute. These results are consistent with in vivo
CPP-DNA adduct studies carried out by 32 P-postlabelling assays (Beach and Gupta,
1994; Nesnow et al., 1994).
CPP-DNA adducts formed in CD-1 mice were examined using HPLC with
LIF detection. In liver and lung DNA digests, four peaks (P1-P4 in Figure 5.1) and
six peaks (P1-P6 in Figure 5.2) were detected respectively (in contrast, no peaks
were detected in animals dosed with corn oil). Fractions obtained from the DNA
digests were collected and analyzed by cryogenic LIF Spectroscopy. cis-3-dG-4-
OH-DCPP was used as a standard for the fluorescence spectroscopic analysis. The
results demonstrated that all peaks were from pyrene-based compounds since they
all exhibited pyrene-specific spectra. This is consistent with the conclusion that
adducts were not formed by diolepoxides of CPP (Beach and Gupta, 1994; Nesnow
et al., 1994). Figures 5.3 and 5.4 show S2 and S, spectra of an adducted peak.
Finally, all peaks were further characterized by their chromatographic similarity to
synthetic CPP metabolites and adduct standards formed in vitro by reacting calf
thymus with CPPE or with trans-CPP-3,4-diol and 4-OH-DCPP, upon the activation
of sulfotransferase.
The sensitivity of this HPLC-LIF system was determined to be on the order
of tenths of femtomoles by injecting different amounts of CPP-3,4-diols (Figure 5.5)
and synthesized CPP-DNA adducts. This sensitivity could be further enhanced with
appropriate optimization. In our experiments less than 30 ug of digested DNA
proved to be sufficient for the detection of the major in vivo CPP-DNA adducts.
Because there are many factors which affect the retention properties of a
compound, such as the room temperature, CPP-3,4-diols were used as internal
standards and reference peaks when necessary. P5 and P6 of Figure 5.2 and P4 of
Figure 5.1 were identified by chromatographic similarities to 4-OH-DCPP, 4-dG-
DCPP, and CPP-dA adducts. CPP-3,4-diols were not used as internal standards in
assisting the identification of these peaks since the fractions have very different
chromatographic properties. CPP-dA adduct standards were obtained by reacting
CPPE with [3H]adenyl calf thymus DNA (Hsu et al., 1996b).
Our results suggest that P1 in liver DNA digests (Figure 5.1) is trans-3-dG-
4-OH-DCPP since it has similar chromatographic characteristics to as the minor dG
adduct obtained from the reaction of CPPE with [3H]guanyl calf thymus DNA (Hsu
et al., 1996b); P2 and P3 are a cis diastereomeric pair of 3-dG-4-OH-DCPP since
they co-migrate with the two major products prepared from CPPE reacting with dG
(Hsu et al., 1996a); and P4 is trans-3-dA-4-OH-DCPP. Similarly, peaks found in
lung samples (Figure 5.2) are trans 3-dG-4-OH-DCPP (P1), two diastereomers of
cis-CPP-3-dG-4-OH-DCPP (P2 and P3), cis-CPP-3,4-diol (P4), cis-3-dA-4-OH-
DCPP (P5), and 4-OH-DCPP (P6).
The relative amounts of material in each peak was estimated by integrating
the peak areas. A standard curve was constructed using injections of standards with
known concentrations. The concentration of adduct in each peak was then estimated
using this standard curve. The fluorescence intensity of adducts was normalized to
that of trans-CPP-3,4-diol since the fluorescence characteristics of different
compounds is known to vary greatly. This data is presented in Table 5.1 which
shows the relative amount of each adduct as a percentage of the total adducts for
a given sample.
5.4 Discussion
This present investigation was undertaken to identify the CPP-DNA adducts
formed using a CPP-carcinogenesis susceptible mouse model. Based on these
results, major electrophilic metabolites of CPP were deduced. Previous studies
using 32P-postlabelling techniques suggest that the CPP-DNA adducts formed in
vivo were derived from CPPE and they appeared to be dG-substituted (except in one
study a minor adduct was found to be dA-substituted) (Beach and Gupta, 1994;
Nesnow et al., 1994). Our results lead to the conclusion that all detected in vivo
adducts are CPPE derivatives, however, trans-CPP-3,4-diol and 4-OH-DCPP, upon
activation of sulfotransferase, may also be responsible for DNA-binding.
Additionally, the detection of CPP metabolites suggests the formation of unstable
adducts.
The possibility of formation of the 3,4-dihydrodiol 9,10-epoxide and the
9,10-dihydrodiol 3,4-epoxide of CPP was proposed by the study of oxidation of
CPP using mouse and human microsomes and selected cytochrome P450 enzymes
(Sahali et al., 1992; Kwon et al., 1992). They are, however, not the adduct-forming
species in this study. In fact, the major hemoglobin adduct formed by a single dose
of CPP in CD-1 mice was shown to be CPPE-substituted histidine. Also, a labile
ester adduct of CPPE appeared when mice were dosed with CPP every three days
for 40 days by the presence of CPP-3,4-diols (Kwon, 1992).
trans-CPP-3,4-diol, the principal metabolite of CPP (Gold and Eisenstadt,
1980; Eisenstadt et al., 1981; Sahali et al., 1992), may play a role in the DNA
modification of CPP. DNA adducts found in CPP-treated Sprague-Dawley rat liver
were concluded to be adducted by CPPE (Beach and Gupta, 1994). Our findings
suggest that these adducts may also be formed by sulfotransferase-activated trans-
CPP-3,4-diol, since same major DNA adducts were formed by either CPPE or trans-
CPP-3,4-diol in the presence of Sprague-Dawley rat liver cytosol and PAPS (Hsu
et al., 1996b). Similarly, some adducts, such as P1, P2, and P3 in Figure 5.1, could
be formed by either CPPE or sulfotransferase-activated trans CPP-3,4-diol or by
both, since high sulfotransferase activity was found in hepatic cytosol of CD-1 mice
for another benzylic hydroxyl metabolite of 3,4-dihydroCPP, 4-OH-DCPP (Surh et
al., 1993).
P6 of Figure 5.2 exhibits similar retention property as 4-OH-DCPP. This
result suggests that sulfotransferase-activated 4-OH-DCPP in CD-1 mice may also
serve as an adduct-forming species of CPP. 4-OH-DCPP is a better substrate for
sulfotransferases when compared to CPP-3,4-diols (Surh et al., 1993). In addition,
a higher level of DNA binding was observed when 4-OH-DCPP was incubated with
human liver post-mitochondrial supernatant in the presence than in the absence of
PAPS (Surh and Tannenbaum, 1996). Thus, it would be worthwhile to further
investigate the role of 4-OH-DCPP in CPP carcinogenesis.
LIF Spectroscopy provides the sensitivity and selectivity required by this
study. The sensitivity of the HPLC-LIF system was determined to be on the order
of tenths of femtomoles. This detection limit is comparable to that of radioactive
postlabelling techniques and can be further improved with proper optimization. A
linear correlation existed between the amount of trans-CPP-3,4-diol injected on the
column and the integrated area of the HPLC-LIF peak over a range of 5 fmol to 1
pmol (Figure 5.5). This provides the means to estimate concentrations of adducts
and metabolites. Notably, this system offers the capability of detecting CPP
metabolites which was not possible in previous studies employing postlabelling
techniques (Beach and Gupta, 1994; Nesnow et al., 1994). The detection of CPP-
3,4-diol and 4-OH-DCPP suggest the formation of unstable CPP-DNA adducts, such
as N7-dG or phosphate adducts. As a test of this inference, DNA isolated from the
reaction of CPPE-treated [3H]guanyl calf thymus DNA was heated and resulted in
two modified fractions were detected on our HPLC-radiochromatogram. Further
investigation of these fractions showed that they were chromatographically distinct
from the trans- and cis- dG adduct standards that were obtained from the enzymatic
digestion of this reaction mixture (Hsu et al., 1996c). These findings might be due
to the depurination of N7-dG adducts upon heating or acid-catalysis (Humphreys
and Gurngerich, 1991). QAIGEN Genomic-tip was employed to ensure that CPP
metabolites were not caused by cleavage of stable CPP-DNA adducts during the
DNA isolation.
Cryogenic fluorescence spectroscopy (40 K) eliminates the problems of
spectral broadening and quenching seen in room temperature fluorescence.
Additionally, fluorescence line narrowing (FLN) spectroscopy can provide detailed
structural information. Line-narrowed spectra are obtained by exciting a compound
into the origin of the first excited state,S 1. However, in FLN spectroscopy only a
small population of molecules are actually excited making this a rather insensitive
spectroscopic method. S2 excitation, on the other hand, provides less structural
information but is extremely sensitive. The laser was tuned to 355 nm and 346 nm
for SI and S2 excitation of pyrene-based compounds. Excitation of pyrene-based
compounds at 346 nm (S2 excitation) results in an intense fluorescence emission
peak at 378 nm, whereas excitation at 355 nm (SI excitation) results in two sharp
peaks around 376 nm. A survey of similar non-pyrene containing PAHs such as
benzo[a]anthracene, chrysene, and phenanthrene showed these fluorescence
characteristics to be unique to pyrene containing compounds. An intense
fluorescence peak at 378 nm was observed in all fractions assayed upon S2
excitation. Subsequent analysis of selected fractions by FLN spectroscopy further
confirmed the presence of a pyrene moiety.
Our results here illustrate the utility of the combination HPLC-LIF and
cryogenic fluorescence spectroscopy in characterizing carcinogen-DNA adducts.
This combination analysis also allows sensitive and specific investigation of
metabolites and protein adducts derived from fluorescent xenobiotics. However, a
quantitative measurement may rely on the availability of various of standards due
to the differences in fluorescence characteristics.
In conclusion, our findings confirm that CPPE is the major DNA adduct-
forming metabolite of CPP. Additionally, we have (1) completed the structural
assignments of in vivo DNA adducts with the use of adduct standards and sensitive
detection system, (2) suggested the formation of unstable adducts due to the
detection of CPP metabolites, and (3) implicated sulfotransferase-activated 4-OH-
DCPP and trans-CPP-3,4-diol as additional adduct-forming species of CPP. The
last conclusion may also apply to previous studies (Beach and Gupta, 1994; Nesnow
et al., 1994). Moreover, this study represents the first adduct investigation of in
vivo PAH adduct formation with using LIF analysis without adduct hydrolysis. It
also promises the possibility of using the utility of the system to monitor carcinogen
exposure in humans.
5.5 Summary
Cyclopenta[cd]pyrene (CPP) is a ubiquitous environmental pollutant. This
present study was undertaken to investigate the formation of the CPP-DNA adducts
using a mouse model and to determine the ultimate carcinogenic metabolite(s) of
CPP. Male CD-1 mice were sacrificed 3 days postdosing i.p. with 7 mg/kg CPP,
and DNA adduct levels in lung and liver tissues were measured. Adduct levels
were found to be approximately 1.5 times higher in liver samples compared to lung
tissue (4.6 pmol/mg lung DNA vs. 3.0 pmol/mg liver DNA). Deoxynucleoside
adducts obtained by enzymatic digestion of DNA were analyzed by HPLC coupled
with Laser Induced Fluorescence (LIF) detection. HPLC separation of the DNA
digests resulted in four and six peaks of liver and lung samples, respectively.
Further analysis indicated that all peaks were derived from CPP 3,4-epoxide (CPPE)
since they all exhibited pyrene-specific spectra when analyzed by a cryogenic LIF
Spectroscopy. Identification of these peaks was also carried out by comparing their
chromatographic properties to synthetic CPP metabolites and adduct standards
formed in vitro. These results suggest that adducts detected in liver DNA digests
are trans-3-deoxyguanosinyl-4-hydroxy-3,4-dihydroCPP (3-dG-4-OH-DCPP), two
diastereomers ofcis-3-dG-4-OH-DCPP, and trans-3-deoxyadenosinyl-4-hydroxy-3,4-
dihydroCPP (3-dA-4-OH-DCPP). Similarly, results suggest that adducts detected
in lung samples are trans-3-dG-4-OH-DCPP, two diastereomers of cis-3-dG-4-OH-
DCPP, cis-CPP-3,4-diol, cis-3-dA-4-OH-DCPP, and 4-OH-DCPP. The detection of
CPP-3,4-diol and 4-OH-DCPP suggests the formation of unstable DNA adducts of
CPP. Furthermore, both CPPE and sulfotransferase-activated trans-CPP-3,4-diol
could be the major reactive ultimate electrophilic and carcinogenic metabolites of
CPP, while sulfotransferase-activated 4-OH-DCPP could be a minor one.
Figure Legends
Figure 5.1 Chromatographic profile of liver DNA from CPP-treated mice
three days after one dose. One hundred ug liver DNA from a CPP-treated mouse
was enzymatically digested and was analyzed by HPLC-LIF system as described in
Materials and Methods. P1 is trans-3-dG-4-OH-DCPP, P2 and P3 are a cis
diastereomeric pair of 3-dG-4-OH-DCPP, and P4 is trans-3-dA-4-OH-DCPP,
tentatively.
Figure 5.2 Chromatographic profile of lung DNA from CPP-treated mice
three days after one dose. Fifty ug lung DNA from a CPP-treated mouse was
enzymatically digested and was analyzed by HPLC-LIF system as described in
Materials and Methods. P1 is trans-3-dG-4-OH-DCPP, P2 and P3 two
diastereomers of cis-CPP-3-dG-4-OH-DCPP, P4 is cis-CPP-3,4-diol, P5 is cis-3-dA-
4-OH-DCPP, P6 is 4-OH-DCPP, tentatively.
Figure 5.3 S2 spectra (excitation at 346 nm, T=4 K) of P1 of liver DNA.
Figure 5.4 S, spectra (excitation at 355 nm, T=4 K) of P1 of liver DNA.
Figure 5.5 Correlation between the amount of trans-CPP-3,4-diol injected
on the column and the integrated area of the HPLC-LIF peak over a range of 5 fmol
and 1 pmol.
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6. Proposals for future research
It is recommended that the following research be undertaken to further
develop and extend the research and results presented above:
1) Structural elucidation of the unstable CPP-DNA products
Characterization of the primary in vitro adduct, CPP-N2-dG, enables the
development of appropriate analytical methods for quantifying in vivo CPP-DNA
adducts. There are some products derived from CPP-dosed tissue DNA that seem
likely to be dihydrodiols. Therefore, structural elucidation of unstable derivatives
will provide further insights into the processes which activate and detoxify CPP and
those that repair the damage caused by in vivo covalent DNA lesions. Additionally,
estimate of these adduct levels may aid the evaluation of CPP genotoxicity.
2) Comparative studies on rates of formation and removal of CPP lesions in
DNA of target and non-target tissues
The organ specificity of CPP carcinogenesis in the mice may be exploited
to gain insight as to which, if any, DNA lesion caused by CPP is a causative factor
in carcinogenesis. The time-dependence of adduct formation and removal is
important to study in order to characterize the possible use of CPP-DNA adducts
as monitors of PAH exposure. To approximate chronic human exposure, a study
of the formation and persistence of CPP-DNA adducts as a function of the dosing
regimen is also necessary.
3) In vitro physical binding experiments
The possible role of intercalative binding and adduct formation in
mutagenesis and carcinogenesis initiated by PAH diol epoxides has been studied and
discussed (Geacintov, 1986; Harvey et al., 1985). In a cellular environment, the
ability of a given PAH diol epoxide derivative to form intercalative non-covalent
complexes with DNA prior to covalent binding is considered to be an important
factor. Therefore, intercalative binding is an important factor in determining the
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biological activities of PAHs.
4) Laser spectroscopic studies of CPP-DNA structure types
Considerable progress on the elucidation of structurally different types of
adducts has been made using spectroscopic techniques including fluorescence
quenching. The BPDE-DNA adducts have been classified as type I and II. Type
I refers sites in which the aromatic plane of pyrene appears to be nearly parallel
(with 25-300) to the planes of the unmodified DNA bases. Such adducts may be
viewed as interior (i.e., quasi-intercalated). Type II sites are characterized by a
lower degree of intercalation between the pyrenyl moiety and the bases and,
therefore, may be viewed as exterior. The result obtained here may have the
potential for distinguishing between CPP adduct formation in DNA and for
monitoring the fates of CPP adducts as a function of time in repair-competent cells.
It has been speculated that type I adducts are more efficiently repaired.
5) Attempt the application of the methodology described in this report to
samples obtained from humans
The profile of CPP-DNA adduct formed in vitro as well as in mice and the
availability of a sensitive and reproducible method for adduct detection and
quantification should permit analysis DNA from exposed humans.
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